Affordable Care Act (ACA); ACA subsidies and tax credits; Telehealth flexibilities; Mental Health Care; Youth Mental Health; Site neutral payment reform; Transparency in coverage; Surprise Billing; 2025 Proposed NBPP/Individual Market/ACA exchanges; Rural healthcare; Prior Authorization; Hospital Consolidation; Health Equity Index reward factor; Employer-provided health coverage; Cyber Attack
S.2556 - Improving CARE for Youth Act
To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day.
Sponsor: Sen. Carper, Thomas R. [D-DE]
H.R.3838 - Preventing Maternal Deaths Reauthorization Act of2023
To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes.
Sponsor: Rep. Burgess, Michael C. [R-TX-26]
H.R. 5378 Lower Costs, More Transparency Act
To promote price transparency in the health care sector, and for other purposes. Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
H.R.4531 - Support for Patients and Communities Reauthorization Act
To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes. Sponsor: Rep. Guthrie, Brett [R-KY-2]
Medicaid Redeterminations & renewals; Same-day billing restrictions in Medicaid; Medicare Advantage; 340B Program
H.R.5746 - Addressing Whole Health in Medicare Advantage Act
To amend title XVIII of the Social Security Act to expand the availability of supplemental benefits to certain Medicare Advantage enrollees.
Sponsor: Rep. Bilirakis, Gus M. [R-FL-12]
H.R.5380 -To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. To amend title XVlll of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.
Sponsor: Rep. Sarbanes, John P. [D-MD-3]
H.R.2880 - Protecting Patients Against PBM Abuses Act
To amend title XVIII of the Social Security Act to establish certain requirements for pharmacy benefit managers under part D of the Medicare program.
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
H.R.5385 - Medicare PBM Accountability Act
To amend title XVIII of the Social Security Act to establish phannacy benefit manager reporting requirements with respect to prescription drug plans and MA-PD plans under Medicare part D.
Sponsor:Rep. Landsman, Greg [D-OH-1]
H.R.5388 - Supporting Innovation for Seniors Act
To amend title XVIII of the Social Security Act to provide coverage of certain technologies and medical devices under the Medicare program. Sponsor: Rep. Balderson, Troy [R-OH-12]
Covid Therapeutics; Cell & Gene therapy; Step Therapy
H.R.5372 - Expanding Seniors' Access to Lower Cost Medicines Act of2023
-To amend Title XVlll of the Social Security Act to facilitate midyear formulary changes for biosimilars.
-Sponsor: Rep. Joyce, John [R-PA-13]
H.R.7312 - EPCS 2.0 Act
-To provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage.
-Sponsor: Rep. Kuster, Ann M. [D-NH-2]
H.R.5376 - Inflation Reduction Act of2022
-Prescription Drug Pricing Refonn
-Sponsor: Rep. Yarmuth, John A. [D-KY-3]
Duration: January 1, 2008
to
present
General Issues: Health Issues , Medicare/Medicaid , Pharmacy , Taxation/Internal Revenue Code , Budget/Appropriations
Spending: about $323,700 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), White House Office, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Personnel Management (OPM), Office of Management & Budget (OMB), Treasury - Dept of, Centers For Medicare and Medicaid Services (CMS),, U.S. Senate,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Sunee Mickle Vice President of Government and Community Relations
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 19.
Original Filing: 301565721.xml
Lobbying Issues
Affordable Care Act (ACA); ACA subsidies and tax credits; Telehealth flexibilities; Mental Health Care; Youth Mental Health; Site neutral payment reform; Transparency in coverage; Surprise Billing; 2025 Proposed NBPP/Individual Market/ACA exchanges; Rural healthcare; Prior Authorization; Hospital Consolidation; Health Equity Index reward factor; Employer-provided health coverage; Cyber Attack
S.2556 - Improving CARE for Youth Act
To amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services and primary care services furnished on the same day.
Sponsor: Sen. Carper, Thomas R. [D-DE]
H.R.3838 - Preventing Maternal Deaths Reauthorization Act of2023
To amend title III of the Public Health Service Act to reauthorize Federal support of States in their work to save and sustain the health of mothers during pregnancy, childbirth, and the postpartum period, to eliminate disparities in maternal health outcomes for pregnancy-related and pregnancy associated deaths, to identify solutions to improve health care quality and health outcomes for mothers, and for other purposes.
Sponsor: Rep. Burgess, Michael C. [R-TX-26]
H.R. 5378 Lower Costs, More Transparency Act
To promote price transparency in the health care sector, and for other purposes. Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
H.R.4531 - Support for Patients and Communities Reauthorization Act
To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes. Sponsor: Rep. Guthrie, Brett [R-KY-2]
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicaid Redeterminations & renewals; Same-day billing restrictions in Medicaid; Medicare Advantage; 340B Program
H.R.5746 - Addressing Whole Health in Medicare Advantage Act
To amend title XVIII of the Social Security Act to expand the availability of supplemental benefits to certain Medicare Advantage enrollees.
Sponsor: Rep. Bilirakis, Gus M. [R-FL-12]
H.R.5380 -To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. To amend title XVlll of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.
Sponsor: Rep. Sarbanes, John P. [D-MD-3]
H.R.2880 - Protecting Patients Against PBM Abuses Act
To amend title XVIII of the Social Security Act to establish certain requirements for pharmacy benefit managers under part D of the Medicare program.
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
H.R.5385 - Medicare PBM Accountability Act
To amend title XVIII of the Social Security Act to establish phannacy benefit manager reporting requirements with respect to prescription drug plans and MA-PD plans under Medicare part D.
Sponsor:Rep. Landsman, Greg [D-OH-1]
H.R.5388 - Supporting Innovation for Seniors Act
To amend title XVIII of the Social Security Act to provide coverage of certain technologies and medical devices under the Medicare program. Sponsor: Rep. Balderson, Troy [R-OH-12]
Agencies Lobbied
U.S. Senate
Lobbying Issues
Covid Therapeutics; Cell & Gene therapy; Step Therapy
H.R.5372 - Expanding Seniors' Access to Lower Cost Medicines Act of2023
-To amend Title XVlll of the Social Security Act to facilitate midyear formulary changes for biosimilars.
-Sponsor: Rep. Joyce, John [R-PA-13]
H.R.7312 - EPCS 2.0 Act
-To provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage.
-Sponsor: Rep. Kuster, Ann M. [D-NH-2]
H.R.5376 - Inflation Reduction Act of2022
-Prescription Drug Pricing Refonn
-Sponsor: Rep. Yarmuth, John A. [D-KY-3]
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 18.
Original Filing: 301528937.xml
Lobbying Issues
Affordable Care Act (ACA), ACA subsidies; Telehealth; Mental Health, Mental Health Rule, Youth Mental Health Access; Site Neutrality/Site neutral payment reform and Fair Hospital Billing; Transparency in coverage; Surprise Billing; Rural healthcare access; Prior Authorization; Provider Workforce Shortages;; Telehealth payment parity requirements; Parity; Provider Directory Accuracy
S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
To amend titles XVIII and XIX of the Social Security Act to expand the mental health care workforce and services, reduce prescription drug costs, and extend certain expiring provisions under Medicare and Medicaid, and for other purposes.
Sponsor: Sen. Wyden, Ron [D-OR]
S.1869 - SITE Act
To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
Sponsor: Sen. Braun, Mike [R-IN]
H.R.3417 - FAIR Act
To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider. Sponsor: Rep. Hern, Kevin [R-OK-1]
H.R. 5378 Lower Costs, More Transparency Act
To promote price transparency in the health care sector, and for other purposes. Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
H.R.3630 - No Surprises Act
To amend title XXVII of the Public Health Service Act to protect health care consumers from surprise billing practices, and for other purposes. Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]
Agencies Lobbied
U.S. Senate
Lobbying Issues
Provider Directories; Medicaid Redeterminations & renewals; Same-day billing restrictions in Medicaid; Medicare Advantage Health Equity Index; Star Ratings in Medicare Advantage; Payment under the Informal Dispute Resolution (IDR) process; Medicare Advantage; Site Neutral Payments and Payment Accuracy; MA RADY Rule; Medicare Advantage Advance Rate Notice;
H.R.5746 -Addressing Whole Health in Medicare Advantage Act
To amend title XVIII of the Social Security Act to expand the availability of supplemental benefits to certain Medicare Advantage enrollees. Sponsor: Rep. Bilirakis, Gus M. [R-FL-12]
H.R.5380 - To amend title XVlll of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage.
Sponsor: Rep. Sarbanes, John P. [D-MD-3]
H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program. To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program.
Sponsor: Rep. Malliotakis, Nicole [R-NY-11]
S.2973 - Modernizing and Ensuring PBM Accountability Act
To amend titles XVIII and XIX of the Social Security Act to establish requirements relating to pharmacy benefit managers under the Medicare and Medicaid programs, and for other purposes.
Sponsor: Sen. Wyden, Ron [D-OR]
Agencies Lobbied
U.S. Senate
Lobbying Issues
Insulin Out of Pocket Costs; Covid Therapeutics; Generics Access; Gene Therapy
S. 150 -Affordable Prescriptions for Patients Act of 2023
A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. John Cornyn (R-TX)
S. 127 - Pharmacy Benefit Manager Transparency Act of 2023
A bill to prevent unfair and deceptive acts or practices and the dissemination of false infonnation related to pharmacy benefit management services for prescription drugs, and for other purposes.
Sponsor: Sen. Maria Cantwell (D-WA)
S.1339 - Pharmacy Benefit Manager Reform Act
To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage.
Sponsor: Sen. Sanders, Bernard [I-VT]
S. 142 - Preserve Access to Affordable Generics and Biosimilars Act
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry ofbiosimilar biological products and interchangeable biological products.
Sponsor: Sen. Amy Klobuchar (D-MN)
H.R.5372 - Expanding Seniors' Access to Lower Cost Medicines Act of2023
To amend Title XVIII of the Social Security Act to facilitate midyear formulary changes for biosimilars. Sponsor: Rep. Joyce, John [R-PA-13]
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 18, 2023.
Original Filing: 301505041.xml
Lobbying Issues
Affordability; Affordable Care Act; Mental Health/Youth Mental Health; Maternal Health; Health Equity; Site Neutrality/site neutral payment reform; Fair Hospital Billing; Transparency in coverage; Surprise Billing; Government shutdown; Rural healthcare access; 340B transparency; HIPAA modernization; Artificial intelligence (AI); Preventative services
S.1869 - SITE Act
To amend title XVIII of the Social Security Act and title XXVII of the Public Health Service Act to ensure fair billing practice for items and services furnished by off-campus hospital locations, to amend such title XVIII to provide for payments for graduate nursing education costs, and for other purposes.
Sponsor: Sen. Braun, Mike [R-IN]
H.R. 3561, The Patient Act of 2023
To promote hospital and insurer price transparency, and for other purposes. Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
H.R.3417 - FAIR Act
To ensure fair billing practices for items and services furnished by off-campus outpatient departments of a provider. Sponsor: Rep. Hern, Kevin [R-OK-1]
H.R. 5378 Lower Costs, More Transparency Act
To promote price transparency in the health care sector, and for other purposes. Sponsor: Rep. McMorris Rodgers, Cathy [R-WA-5]
H.R.4822 Health Care Price Transparency Act of 2023
To improve price transparency with respect to certain health care services, and for other purposes. Sponsor: Rep. Smith, Jason [R-MO-8]
H.R.4531 - Support for Patients and Communities Reauthorization Act
To reauthorize certain programs that provide for opioid use disorder prevention, recovery, and treatment, and for other purposes. Sponsor: Rep. Guthrie, Brett [R-KY-2]
H.R.4509 - Transparency in Billing Act
To amend the Employee Retirement Income Security Act of 1974 to require group health plans and health insurance issuers offering group health insurance coverage to only pay claims submitted by hospitals that have in place policies and procedures to ensure accurate billing practices, and for other purposes.
Sponsor: Rep. Foxx, Virginia [R-NC-5]
H.R.4508 - Hidden Fee Disclosure Act
To amend the Employee Retirement Income Security Act of 1974 to clarify and strengthen the application of certain employer-sponsored health plan disclosure requirements. Sponsor: Rep. Courtney, Joe [D-CT-2]
H.R.4507 - Transparency in Coverage Act of 2023
To amend the Employee Retirement Income Security Act of 1974 to promote transparency in health coverage and reform pharmacy benefit management services with respect to group health plans, and for other purposes. Sponsor: Rep. Good, Bob [R-VA-5]
H.R.4527 - Health DATA Act
To amend the Employee Retirement Income Security Act of 1974 to ensure plan fiduciaries may access de-identified information relating to health claims, and for other purposes. Sponsor: Rep. Chavez-DeRemer, Lori [R-OR-5]
H.R.5647 - Childhood Cancer Clinical Trials Act
To amend title XXVII of the Public Health Service Act to require out-of-network coverage for qualified individuals diagnosed with a rare pediatric disease participating in approved clinical trials, and for other purposes. Sponsor: Rep. McCaul, Michael T. [R-TX-10]
S.652 - Safe Step Act
To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes.
Sponsor: Sen. Murkowski, Lisa [R-AK]
H.R.5688 - Bipartisan HSA Improvement Act of 2023
To amend the Internal Revenue Code of 1986 to improve health savings accounts. Sponsor: Rep. Smucker, Lloyd [R-PA-11]
H.R.5687 - HSA Modernization Act of 2023
To amend the Internal Revenue Code of 1986 to modernize health savings accounts. Sponsor: Rep. Van Duyne, Beth [R-TX-24]
Agencies Lobbied
U.S. Senate
Lobbying Issues
Provider Directories; Medicaid Redeterminations
H.R.3284 - Providers and Payers COMPETE Act
To require the Secretary of Health and Human Services to submit an annual report on the impact of certain Medicare regulations on provider and payer consolidation.
Sponsor: Rep. Burgess, Michael C. [R-TX-26]
Agencies Lobbied
U.S. Senate
Lobbying Issues
Insulin Out of Pocket Charges; Finance PBNM Framework Proposals; Covid Vaccines
S. 150 - Affordable Prescriptions for Patients Act of 2023
A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. John Cornyn (R-TX)
S. 127 - Pharmacy Benefit Manager Transparency Act of 2023
A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes. Sponsor: Sen. Maria Cantwell (D-WA)
S.1067 - Ensuring Timely Access to Generics Act of 2023
To amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Shaheen, Jeanne [D-NH]
S.1114 - Expanding Access to Low-Cost Generics Act of 2023
To amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period. Sponsor: Sen. Smith, Tina [D-MN]
S.1269 - INSULIN Act of 2023
To reduce the price of insulin and provide for patient protections with respect to the cost of insulin. Sponsor: Sen. Shaheen, Jeanne [D-NH]
S.1339 - Pharmacy Benefit Manager Reform Act
To provide for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Sponsor: Sen. Sanders, Bernard [I-VT]
S.2305 - Biosimilar Red Tape Elimination Act
To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Sponsor: Sen. Lee, Mike [R-UT]
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 20, 2023.
Original Filing: 301490124.xml
Lobbying Issues
Affordability; COVID commercialization; Affordable Care Act; Telehealth-extending flexibilities; Youth Mental Health - timing of legislation introduction, school-based solutions; Health equity; Appropriations; Surprise Billing; OPM Federal Employee Health Benefits Program; Association Plans (AHPs)
S. 1001 Telehealth Expansion Act of 023
To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.
Sponsor: Sen. Daines, Steve [R-MT]
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage Advance Rate Notice and Prior Authorization Legislation; Medicaid Redeterminations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Insulin Out of Pocket Charges;
S. 150 - Affordable Prescriptions for Patients Act of 2023
Sponsor: Sen. John Comyn (R-TX)
S. 127 - Pharmacy Benefit Manager Transparency Act of2023
Sponsor: Sen. Maria Cantwell (D-WA)
S. 1067 -- Ensuring Timely Access to Generics Act of 2023
Sponsor: Sen. Maria Dantwell (D-WA)
S. 1114 - Expanding Access to Low-Cost Generics Act of 2023
Sponsor: Sen. Shaheen, Jeanne (D-NH)
S. 1269 - INSULIN Act of 2023
Sponsor: Sen. Smith, Tina (D-NH)
S. 1339 - Pharmacy Benefit Manager Reform Act
Sponsor: Sen Sanders, Bernard (I-VT)
S. 6 - Biosimilar Red Tape Elimination Act
Sponsor: Sen Lee, Mike (R-UT)
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 19, 2023.
Original Filing: 301459103.xml
Lobbying Issues
REL Data Standards; Addressing Workforce Shortages;
Telehealth payment parity requirements; Affordability; Affordable Care Act; Youth Mental Health; Maternal Health; Addressing Workforce Shortages; Maternal Health Equity; Appropriations;
H.R. 485 Protecting Health Care for All Patients Act - Protecting Health Care for All Patients Act of 2023
Sponsor: Rep. Cathy McMorris Rodgers (R-WA-05)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage Prior Authorization Legislation
Agencies Lobbied
U.S. Senate
Lobbying Issues
INSULIN Act; Insulin Out of Pocket Charges;
S. 148 - Stop STALLING Act
Sponsor: Sen. Amy Klobuchar (D-MN)
S. 142 - Preserve Access to Affordable Generics and Biosimilars Act
Sponsor: Sen. Amy Klobuchar (D-MN)
S. 150 - Affordable Prescriptions for Patients Act of 2023
Sponsor: Sen. John Comyn (R-TX)
S. 127 - Pharmacy Benefit Manager Transparency Act of2023
Sponsor: Sen. Maria Cantwell (D-WA)
S. 954 - Affordable Insulin Now Act of 2023
Sponsor: Sen. Raphael Warnock (D-GA)
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2023.
Original Filing: 301435033.xml
Lobbying Issues
Telehealth; COVID-19; Health Equity Issues; Mental Health Parity; Affordability; Telehealth; Coverage ofCOVID-19 Inflation Reduction Act; No Surprises Act; REL data; Covid transition/PRE; Pre-deductible/site restriction telehealth extension; parity enforcement and implementation; funding or mental health programs; provider directories; No Surprises Act; Qualifying Payment Amount; Section 204;
H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022
Sponsor: Rep. Frank Pallone (D-NJ-06)
H.R. 7780 - Mental Health Matters Act
Sponsor: Rep. Mark DeSaulnier (D-CA-11)
H.R. 7585 - Health Equity and Accountability Act of2022
To improve the health of minority individuals, and for other purposes. Sponsor: Rep. Robin Kelly (D-IL-02)
H.R. 959 - Black Maternal Health Momnibus Act of 2021
Sponsor: Rep. Lauren Underwood (D-IL-14)
S. 346 - Black Maternal Health Momnibus Act of 2021
Sponsor: Sen. Cory Booker (D-NJ)
H.R. 432 - Mental Health Access Improvement Act of2021
To amend title XVIII of the Social Security Act to provide for the coverage of marriage and family therapist services and mental health counselor services under part B of the Medicare program, and for other purposes.
Sponsor: Rep. Mike Thompson (D-CA-04)
S. 828 - Mental Health Access Improvement Act of 2021
A bill to amend title XVIII of the Social Security Act to provide for the coverage of marriage and family therapist services and mental health ounselor services under part B of the Medicare program, and for other purposes.
Sponsor: Sen. John Barrasso (R-WY)
H.R. 3345 - Helping MOMS Act of2021
To amend the American Rescue Plan Act of2021 and title XIX of the Social Security Act to promote extended coverage of pregnant and postpartum omen under the Medicaid program.
ep. Robin Kelly (D-IL-02)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare; Medicare Advantage; Medicaid; Medicaid postpartum coverage; Medicare Advantage provider directories; Medicaid MOE; Consumer Assistance Program; Part D; Center for Medicaid and CHIP Services; Part D changes under IRA; Addressing Health-Related Social Needs and SDOH in Medicaid; Medicare Advantage Prior Authorization;
H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021
Sponsor: Rep. Suzan DelBene (D-WA-01)
S. 3018 - Improving Seniors' Timely Access to Care Act of2021
Sponsor: Sen. Roger Marshall (R-KS)
H.R. 8594 - Restore Protections for Dialysis Patients Act
To amend title XVIII of the Social Security Act to clarify and preserve the breadth of the protections under the Medicare Secondary Payer Act. Sponsor: Rep. Yvette Clarke (D-NY-09)
S. 4750 - Restore Protections for Dialysis Patients Act
A bill to amend title XVIII of the Social Security Act to clarify and preserve the breadth of the protections under the Medicare Secondary Payer Act. Sponsor: Sen. Bob Menendez (D-NJ)
Agencies Lobbied
U.S. Senate
Lobbying Issues
COVID-19 Testing; Prescription drugs; Insulin; Coverage and Commercialization of Testing, Vaccines and Treatments;
Insulin -the Improving Needed Safeguards for Users
of Lifesaving Insulin Now (INSULIN) Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2022.
Original Filing: 301413521.xml
Lobbying Issues
Affordable Care Act (ACA); Telehealth; COVID-19; Extending ARPA Subsidies; Health Equity Issues; Mental Health Parity; Affordability; Telehealth; Coverage of COVID-19 Therapeutics; Inflation Reduction Act; No Surprises Act; Covid Transition/PHE
H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022
Sponsor: Rep. Frank Pallone (D-NJ-06)
H.R. 7780 - Mental Health Matters Act
Sponsor: Rep. Mark DeSaulnier (D-CA-11)
H.R. 959 - Black Maternal Health Momnibus Act of 2021
Sponsor: Rep. Lauren Underwood (D-IL-14)
S. 346 - Black Maternal Health Momnibus Act of 2021
Sponsor: Sen. Cory Booker (D-NJ)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare; Medicare Advantage Reform; Part D Reform; Prior Authorization; Medicare Advantage; Improving the Medicaid & CHIP Application Process
H.R. 2166 - Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Sponsor: Rep. Terri Sewell (D-AL-07)
S. 3018 - Improving Seniors Timely Access to Care Act of 2021
Sponsor: Sen. Roger Marshall (R-KS)
Agencies Lobbied
U.S. Senate
Lobbying Issues
COVID-19 Testing; Prescription drugs; Insulin; Coverage of Testing and Vaccines;
H.R. 3 - Lower Drug Costs Now Act
Sponsor: Rep. Frank Pallone (D-NJ-06)
Insulin -the Improving Needed Safeguards for Users
of Lifesaving Insulin Now (INSULIN) Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Aug. 9, 2022.
Original Filing: 301398659.xml
Lobbying Issues
COVID-19; Telehealth; Extending ARPA Subsidies; Mental Health Parity; OTC Covid Testing; Public Health EMergency; Affordability; End of Public Health Emergency
H.R. 5376 - Build Back Better Act
Sponsor: Rep. John Yarmuth (D-KY-03)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare; Medicare Advantage Reform; Part D Reform; Prior Authorization; Medicare Advantage
Agencies Lobbied
U.S. Senate
Lobbying Issues
COVID-19 Testing; OTC COVID Tests; COVID-19 Oral Antivirals and Medications; Insulin
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 20, 2022.
Original Filing: 301365028.xml
Lobbying Issues
Surprise Billing; COVID-19; Telehealth; Health Equity Issues; OTC COVID testing; Affordability; Oral Antivirals, Transparency, Value-Based care.
H.R. 5376 - Build Back Better Act
Sponsor: Rep. John Yarmuth (D-KY-03)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare; Medicare Advantage Reform; Part D Reform; Medicaid
Agencies Lobbied
U.S. Senate
Lobbying Issues
COVID-19 Testing; OTC COVID Tests; COVID-19 Oral Antkivirals and Medications
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 20, 2022.
Original Filing: 301332815.xml
Lobbying Issues
Affordable Care Act (ACA); Health Care Reform; Surprise Billing; COVID-19; CAA Implementation; Extending Exchange Subsidies
Public Law 117-2 (H.R. 1319) - American Rescue Plan Act of 2021
Sponsor: Rep. John Yarmuth (D-KY-03)
H.R. 5376 - Build Back Better Act
Sponsor: Rep. John Yarmuth (D-KY-03)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare; Medicare Advantage Reform; Part D Reform; Medicaid Coverage Gap
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Rx reform; Prescription drugs; Prescription Drug Reform; OTC COVID Tests
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2021.
Original Filing: 301312577.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Reform; ACA Coverage Improvement; Health Reform; Surprise Billing; Maternal Health; COVID-19; Telehealth/Audio Only; Black Maternal Health; Age adjustments; Health disparities; Health Equity issues; CAA Implementation; Extending Exchange Subsidies;Reconciliation; Health Care Spending; No Surprises Act
H.R. 19 - Lower Costs, More Cures Act of 2021
Sponsor: Rep. Cathy McMorris Rodgers (R-WA-05)
Public Law 117-2 (H.R. 1319) - American Rescue Plan Act of 2021
Sponsor: Rep. John Yarmuth (D-KY-03)
Public Law 117-7 (H.R. 1868) - To prevent across-the-board direct spending cuts, and for other purposes
Sponsor: Rep. John Yarmuth (D-KY-03)
H.R. 1878 - State Health Care Premium Reduction Act of 2021
Sponsor: Rep. Angie Craig (D-MN-02)
H.R. 5260 - Reduced Costs and Continued Cures Act
Sponsor: Rep. Scott Peters (D-CA-52)
H.R. 959 - Black Maternal Health Momnibus Act of 2021
Sponsor: Rep. Lauren Underwood (D-IL-14)
H.R. 3894 - CARING for Social Determinants Act of 2021
Sponsor: Rep. Lisa Blunt Rochester (D-DE-At-Large)
H.R. 4387 - maternal Health Quality Improvement Act of 2021
Sponsor: Rep. Robin Kelly (D-IL-02)
H.R. 4026 - Social Determinants of Health Data Analysis At of 2021
Sponsor: Rep. Robin kelly (D-IL-02)
H.R. 4026 - Social Determinants of Health Data Analysis Act of 2021
Sponsor: Rep. Mike Burgess (R-TX-26)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare; Medicare Advantage Reform; Medicaid; Part D Reform; Medicaid Coverage Gap
Public Law 117-7 (H.R. 1868)
To prevent across-the-board direct spending cuts, and for other purposes
Sponsor: Rep. John Yarmuth (D-KY-03)
H.R. 2166 - To amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans and PACE programs, and for other purposes.
Sponsor: Rep. Terri Sewell (D-AL-07)
H.R. 2166 - Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Sponsor: Rep. Terri Sewell (D-AL-07)
H.R. 4406 - Supporting Medicaid in the U.S. Territories Act of 2021
Sponsor: Rep. Darren Soto (D-FL-09)
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Tax Credits
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes
Sponsor: Rep. John Yarmuth (D-KY-03)
S. Con. Res. 14 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 22 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Sponsor: Sen. Bernie Sanders (I-VT)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout; Rx reform; Prescription drugs; Prescription Drug Reform
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 15, 2021.
Original Filing: 301276596.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Reform; ACA Coverage Improvement; Health Reform; Lower Health Care Costs; Transparency; Surprise Billing; Maternal Health; COVID-19 Response/Relief Packages; Telehealth/Audio Only; COVID-19; Black Maternal Health; Age adjustments; Health disparities; Implementation timetables/deliverables; Health Equities; SEP; Modeling of BCBSA Individual market Proposals; CAA; APCD; CLosing Coverage Gap; Extending Exchange Subsidies; Health Equity Issues;
Public Law 116-260 (H.R.133)
COVID-19 Relief and Fiscal 2021 Omnibus
Consolidated Appropriations Act, 2021
Sponsor: Rep. Henry Cuellar (D-TX-28)
Public Law 117-2 (H.R. 1319)
American Rescue Plan Act of 2021
Sponsor: Rep. John Yarmuth (D-KY-03)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicaid Maternal Health; Medicare Advantage Audio Only; Medicare; Medicare Advantage Reform; Medicaid; Part D Reform;
S. 150 - Ensuring Parity in MA for Audio-Only Telehealth Act of 2021
Sponsor: Sen. Catherine Cortez Masto (D-NV)
Public Law 117-7 (H.R. 1868)
To prevent across-the-board direct spending cuts, and for other purposes
Sponsor: Rep. John Yarmuth (D-KY-03)
S. 4840Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
Sponsor: Sen. Pat Roberts (R-KS)
H.R. 7659 - Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
Sponsor: Rep. Terri Sewell (D-AL-07)
H.R. 2166 - To amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnoses in the determination of risk adjustment for Medicare Advantage plans and PACE programs, and for other purposes.
Sponsor: Rep. Terri Sewell (D-AL-07)
H.R. 2815 - Biosim Act
Sponsor: Rep. Kurt Schrader
H.R. 2846 - Ensuring access to Lower-Cost Medicines for Seniors Act of 2021
Sponsor: Rep. David McKinley (R-WV-01)
H.R. 2166 - Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021
Sponsor: Rep. Terri Sewell (D-AL-07)
Agencies Lobbied
U.S. Senate
Lobbying Issues
ACA Tax Credits; APTC;
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes
Sponsor: Rep. John Yarmuth (D-KY-03)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout; Rx reform; Prescription drugs; Prescription Drug Reform;
H.R. 3 - Lower Drug Costs Now Act
Sponsor: Rep. Frank Pallone (D-NJ-06)
H.R. 2831 - Prompt Approval of Safe Generic Drugs Act
Sponsor: Rep. Nanette Barragan (D-CA-44)
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 19, 2021.
Original Filing: 301258781.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Reform; ACA Coverage Improvement; Health Reform; Lower Health Care Costs; Transparency; Surprise Billing; Maternal Health; COVID-19 Response/Relief Packages; COBRA subsidies; Telehealth/Audio Only; COVID-19; COVID-19 Disaster Relief; Age adjustments; Health disparities; Implementation timetables/deliverables; Cost and Affordability; SEP.
Public Law 116-260 (H.R.133)
COVID-19 Relief and Fiscal 2021 Omnibus
Sponsor: Rep. Henry Cuellar (D-TX-28)
Public Law 117-2 (H.R. 1319)
American Rescue Plan Act of 2021
Sponsor: Rep. John Yarmuth (D-KY-03)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage Audio Only; Medicare Advantage
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment; Vaccine Rollout
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2021.
Original Filing: 301237070.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Care Reform; Individual Health Care Costs; Mental Health; Transparency; Surprise Billing; Senior's health care; NBPP (Notice Benefit and Payment Parameters), COVID-19 Response/Relief Packages; COBRA subsidies; Telehealth/Audio-Only; COVID-19; ACA Tax Credits; Testing Funding Level/Plan Requirements; Silver loading; Reinsurance; COVID-19 Disaster Relief; OWS Connection
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr [D-NJ-6](Introduced 07/09/2019)
H.R.5826 - 116th Congress (2019-2020)
Consumer Protections Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Neal, Richard [D-MA-1] (Introduced 02/10/2020)
Public Law 116-127 (H.R.6201) - 116th Congress
First Coronavirus Response Act
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6810 - 116th Congress
Health Care Protection Act
Sponsor: Rep. Rodney Davis (R-IL-13)
Public Law 116-123 (H.R. 074) - 116th Congress
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6800 - - 116th Congress
HEROES Act
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6545 - 116th Congress
Health Insurance Marketplace Affordability Act of 2020
Sponsor: Rep. Stephanie Murphy (D-FL-07)
Public Law 116-136 (H.R. 748) - 116th Congress
Third Coronavirus Stimulus Package
Sponsor: Rep. Joe Courtney (D-CT-02)
H.R. 3107 - 116th Congress
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. DelBene, Suzan K. (D-WA-1)
Public Law 116-260 (H.R.133) - 116th Congress
COVID-19 Relief and Fiscal 2021 Omnibus
Sponsor: Rep. Henry Cuellar (D-TX-28)
S. 1895 - 116th Congress
Lower Health Care Costs Act
Sponsor: Sen. Lamar Alexander (R-TN)
S. 3606 - 116th Congress
Health Force and Resilience FOrce Act of 2020
Sponsor: Sen. Kirsten Gillibrand (D-NY)
Public Law 116-159 (H.R. 8337) - 116th Congress
Continuing Appropriations Act, 2021 and Other Extensions Act
Sponsor: Rep. Nita Lowey (D-NR-17)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage Audio Only; MOMS Act
H.R. 7659 - 116th Congress
Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
To amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnosis in the determination of risk adjustment for Medicare Advantage plans, and for other purposes.
Sponsor: Rep. Terri Sewell (D-AL-07)
S. 4840 - 116th Congress
Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
Sponsor: Sen. Pat Roberts (R-KS)
H.R. 4996 - 116th Congress
Helping MOMS Act of 2020
Sponsor: Rep. Robin Kelly (D-IL-02)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax Extenders; ACA tax credits
H.R.748 - 116th Congress (2019-2020)
Third Coronavirus Stimulus Package (CARES Act)
To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
COVID-19 Testing; COVID-19 Vaccine Strategy and Treatment
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2020.
Original Filing: 301223345.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Care Reform; Risk Adjustment; Opioids; Individual Health Care Costs; Mental Health; Reinsurance; Transparency; Surprise Billing; Prior Authorization; All payer claims database; Medicare for All; Senior's health care; Community health; NBPP (Notice Benefit and Payment Parameters), COVID-19 Response/Relief Packages, Healthcare access/privacy; Risk Corridors; COBRA; Telehealth/Audio-Only; CDC Guidance Testing; COVID-19; Postal Reform; Mental Health Parity (MHPAEA); Premium Credits; ACA Tax Credits
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr [D-NJ-6](Introduced 07/09/2019)
H.R.5826 - 116th Congress (2019-2020)
Consumer Protections Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Neal, Richard [D-MA-1] (Introduced 02/10/2020)
Public Law 116-127 (H.R.6201) - 116th Congress - Second Session
First Coronavirus Response Act
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6810 - 116th Congress - Second Session
Health Care Protection Act
Sponsor: Rep. Rodney Davis (R-IL-13)
Public Law 116-123 (H.R. 074) - 116th Congress - Second Session
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6800 - - 116th Congress - Second Session
HEROES Act
Sponsor: Rep. Nita Lowey (D-NY-17)
Public Law 116-139 (H.R. 266) - 116th Congress - First Session
Vehicle for COVID-19 Small Business, Hospital and Testing Funds
Sponsor: Rep. Betty McCollum (D-MN-04)
H.R. 6545 - 116th Congress - Second Session
Health Insurance Marketplace Affordability Act of 2020
Sponsor: Rep. Stephanie Murphy (D-FL-07)
Public Law 116-136 (H.R. 748) - 116th Congress - Second Session
Third Coronavirus Stimulus Package
Sponsor: Rep. Joe Courtney (D-CT-02)
H.R. 2781 - 116th Congress - First Session
EMPOWER for Health Act of 2019
Amend title VII of the public Health Service Act to reauthorize certain programs relating to the health professions workforce, and for other purposes.
Sponsor: Rep. Jan Schakowsky (D-IL-09)
H.R. 2328 - 116th Congress - First Session
Community Health Investment, Modernization, and Excellence Act of 2019
To reauthorize and extend funding for community health centers and the National Health Servvice Corps.
Sponsor: Rep. Tom O'Halleran (D-AZ-01)
H.R. 6800 - 116th Congress - Second Session
The HEROES Act
Making emergency supplemental appropriations for the fiscal year ending September 30, 2020, and for other purposes.
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 7723 - 116th Congress - Second Session
Behavioral Health Coordination and Communication Act of 2020
To Establish the position of Interagency Coordinator for Behavioral Health to coordinate the programs and activities of the Federal Government relating to mental health and for other purposes.
Sponsor: Rep. Joe Kennedy III (D-MA-04)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicaid Expansion; Medicaid General; Privacy; Medicare Prescription Drug Pricing; CMS; CHIP; MACRA; Provider funding; Rate Notice and Call Letter.
H.R. 3107 - 116th Congress (2019-2020)
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. Suzan DelBene (D-WA)
H.R. 7659 - 116th Congress - Second Session
Ensuring Parity in MA for Audio-Only Telehealth Act of 2020
To amend title XVIII of the Social Security Act to require the inclusion of certain audio-only diagnosis in the determination of risk adjustment for Medicare Advantage plans, and for other purposes.
Sponsor: Rep. Terri Sewell (D-AL-07)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Tax Extenders; ACA tax credits
H.R.748 - 116th Congress (2019-2020)
Third Coronavirus Stimulus Package (CARES Act)
To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
H.R. 3107 - 116th Congress
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. Suzan DelBene(D-WA), Rep. Mike Kelly (R-PA), Roger Marshal (R-KS), and Ami Bera (D-CA)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Opioids; Drug Pricing; COVID-19 Tesing
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 20, 2020.
Original Filing: 301201374.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Care Reform; Rural Healthcare; Risk Adjustment; CSRs; Opioids; Marketplace Stability; Individual Market Reform; Association Health Plans (AHPs); Value-Based Reimbursement; Health Care Costs; Mental Health; Reinsurance; Transparency; Silverloading; Interoperability; Health IT; Surprise Billing; Small Business; Prior Authorization; Provider Directories; Health Reimbursement Arrangements (HRAs); Education and Enrollment; Consumer-facing app disclosures; Negotiated Rate Disclosure; Medicare for All; Medicare Buy-In, Social determinants of health, Community Health, Cybersecurity, NBPP(Notice Benefit and Payment Parameters);Provider directories; Maternal Health; Senior's health care; COVID-19 Response/Relief Packages; Healthcare access/privacy; Risk Corridors; COBRA; Telehealth; SEPs; CDC Guidance Testing; Safe Harbor; Prior Authorizations; COVID-19 Test Without Cost-Sharing.
H.R. 1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7](Introduced 2/27/19)
S. 1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN](Introduced 6/19/2019)
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr [D-NJ-6](Introduced 07/09/2019)
H.R.3439 - 116th Congress (2019-2020)
PATIENT Act
Sponsor: Rep. Beyer, Donald S.,Jr. [D-VA-8](Introduced 06/24/2019)
S. 2546 - 116th Congress (2019-2020)
Safe Step Act
Sponsor: Sen. Lisa Murkowshi (R-Ark)
H.R.5826 - 116th Congress (2019-2020)
Consumer Protections Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Neal, Richard [D-MA-1] (Introduced 02/10/2020)
S.3548 - 116th Congress (2019-2020)
Coronavirus Aid, Relief, and Economic Security Act
Sponsor: Sen. McConnell, Mitch [R-KY](Introduced 03/19/2020)
H.R.5754 - 116th Congress (2019-2020)
Rural ER Access Act
Sponsor: Rep. Green, Mark [R-TN-7](Introduced 02/04/2020)
H.R. 5763 - 116th Congress - Second Session
National Telehealth Strategy and Data Advancement Act
Sponsor: Rep. Greg Gianforte (R-MT At-Large)
H.R.5800 - 116th Congress (2019-2020)
Ban Surprise Billing Act
Sponsor: Rep. Scott, Robert [D-VA-3](Introduced 02/07/2020)
H.R.5916 - 116th Congress (2019-2020)
Transparent Health Care PRicing Act of 2020
Sponsor: Rep. Mike Gallagher (R-WI-08)
Public Law 116-127 (H.R.6201) - 116th Congress - Second Session
First Coronavirus Response Act
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6336 - 116th congress - Second Session
To amend title XI of the Social Security Act to provide for a waiver of payment reductions under the Medicare and Medicaid programs for certain nonapproved capital expenditures undertaken by health care facilities during the COVID-19 emergency.
Sponsor: Rep. Dan Bishop (R-NC_09)
H.R. 6311 - 116th Congress - Second Session
Care for COVID-19 Act
Sponsor: Rep. Raul Ruiz (D-CA-36)
H.R. 6299 - 116th COngress - Second Session
Rapid COverage of COVID-19 Vaccine Act of 2020
H.R. 5816 - 116th Congress - Second Session
Continuing Care for Patients Act of 2020
Sponsor: Rep. Gwen Moore (D-WI-04)
H.R. 5826 - 116th Congress Second Session
Consumer Protections Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Richard Neal (D-MA-01)
H.R. 5924 - 116th Congress Second Session
To amend the Public Health Service Act to authorize a loan repayment program to encourage specialty medicine physicians to serve in rural communities experiencing a shortage of specialty medicine physicians, and for other purposes.
Sponsor: Rep. David McKinley (R-WV-01)
H.R. 6004 - 116th Congress - Second Session
Transparency and Accountability in Health Care Costs and Prices Act of 2020
Sponsor: Rep. Dan Lipinski (D-IL-03)
H.R. 6173 - 116th Congress - Second Session
Covering Coronavirus Test Act of 2020
Sponsor: Rep. Diana DeGette (D-CO-01)
H.R. 6213 - 116th Congress - Second Session
No Cost for COVID-19 Testing Act
Sponsor: Rep. Frederica Wilson (D-FL-24)
H.R. 6222 - 116th Congress - Second Session
Ensuring Affordable COVID-19 Preventative Care Act of 2020
Sponsor: Rep. Jan Schakowsky (D-IL-09)
H.R. 6232 - 116th Congress - Second Session
To require the SEcretary of Health and Human Services, through the National Desaster Medicdal System, to provide for certain laboratory reimbursement for diagnostic testing for COVID-19 in uninsured individuals.
Sponsor: Rep Tony Cardenas (D-CA-29)
H.R. 6231 - 116th Congress - Second Session
Ensuring Access to COVID-19 Preventative Care Act of 2020
Sponsor: Rep. Larry Bucshon (R-IN-08)
H.R. 6263 - 116th Congress - Second Session
To amend title XVIII of the Social Security Acto to waive cost sharing under the Medicare program for certain visits relating to testing for COVID-19.
Sponsor: Rep. John Sarbanes (D-MD-03)
H.R. 6810 - 116th Congress - Second Session
Health Care Protection Act
Sponsor: Rep. Rodney Davis (R-IL-13)
Public Law 116-123 (H.R. 6074) - 116th Congress - Second Session
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6800 - 116th Congress - Second Session
HEROES Act
Sponsor: Rep. Nita Lowey (D-NY-17)
H.R. 6338 - 116th Congress - Second Session
Pandemic Healthcare Access Act
Sponsor: Rep. Ted Budd (R-NC-13)
H.R. 5808 - 116th Congress - Second Session
Save Rural Communities Act of 2020
Sponsor: Rep. Jodey Arrington (R-TX-19)
H.R. 7391 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to remove certain geographic and originating site restrictions on the furnishing of telehealth services under the Medicare program.
H.R. 5763 - 116th Congress - Second Session
National Telehealth Strategy and Data Advancement Act
Sponsor: Greg Gianforte (R-MT At-Large)
H.R. 6792 - 116th Congress - Second Session
Improving Telehealth for Underserved Communities Act of 2020
Sponsor: Rep. Adrian Smith (R-NE-03)
H.R. 6918 - 116th Congress - Second Session
Paycheck Recovery Act of 2020
Sponsor: Rep. Pramila Jayapal (D-WA-07)
Public Law - 116-136 (H.R.748) - 116th Congress - First Session
Third Coronavirus Stimulus Package
Sponsor: Rep. Joe Courtney (D-CT-02)
H.R. 3107 - 116th Congress
Improving Senior's Timely Access to Care Act of 2019
Sponsor: Rep. Suzan DelBene (D-WA), Rep. Mike Kelly (R-PA), Rep. Roger Marshal (R-KS0 and Ami Bera (D-CA)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicaid Expansion; Medicare Data Sharing; Privacy; Medicare Prescription Drug Pricing; CMS; Generic drugs (CREATES); MACRA; Drug approval; Provider funding; Coronavirus Medicaid Response; Rate Notice and Call Letter; Prior Authorizations, COVID-19 Test Without Cost-Sharing.
H.R. 3107 - 116th Congress (2019-2020)
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. Suzan DelBene (D-WA), Rep. Mike Kelly (R-PA), Roger Marshal (R-KS) and Ami Bera (D-CA)
H.R. 5833 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to permit the use of certain psychological evaluation via telehealth for Medicare coverage of neurostimulation services for the treatment of chronic pain.
Sponsor: Rep. Bob Latta (R-OK-05)
H.R. 6179 - 116th Congress - Second Session
Increasing Access to Biosimilars Act of 2020
Sponsor: Rep. Tony Cardenas (D-CA-29)
H.R. 6218 - 116th Congress - Second Session
Preserving Patient Access to Home INfusion Act
Sponsor: Rep. Eliot Engel (D-NY-16)
H.R. 6214 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to provide for coverage of testing for COVID-19 at no cost sharing under the Medicare Advantage program.
Sponsor: Rep. Ron Kind (D-WI-03)
H.R. 6484 - 116th Congress - Second Session
Care for COVID-19 Act 2.0
Sponsor: Rep. Raul Ruiz (D-CA-36)
H.R. 6674 - 116th Congress - Second Session
Medicare Crisis Program Act of 2020
Sponsor: Rep. Pramila Hayapal. (D-WA-07)
H.R. 6739 - 116th Congress - Second Session
Ensuring Seniors' Access to COVID Treatments Act
Sponsor: Rep. Sean Casten (D-IL-06)
H.R. 7062 - 116th Congress - Second Session
Affordable Insulin for the COVID-19 Emergency Act
Sponsor: Rep. Maxine Waters (D-CA-43)
H.R. 6583 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to establish a risk corridor program for Medicare Advantage plans during the COVID-19 emergency, and for other purposes.
Sponsor: Rep. Chrissy Houlahan (D-PA-06)
H.R. 6640 - 116th Congress - Second Session
Medicare Advantage COVID Treatment Act
Sponsor: Rep. Debbie Mucarsel-Powell (D-FL-26)
H.R. 6837 - 116th Congress - Second Session
Medicare Accelerated and Advance Payments IMprovement Act of 2020
Sponsor: Rep. Brad Schneider (D-IL-10)
H.R. 7292 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to provide for forgiveness of certain accelerated and advance payments under parts A and B of the Medicare program.
Sponsor: Repm. Marcy Kaptur (D-OH-09)
H.R. 7323 - 116th Congress - Second Session
Medicare Mental Health Inpatient Equity Act of 2019
Sponsor: Rep. Paul Tonko (D-NY-20)
H.R. 7338 - 116th Congress - Second Session
To amend title XVIII of the Social Security Act to permit the Secretary of Health and Human Services to waive requirements relating to the furnishing of telehealth services under the Medicare program, and for other purposes.
Sponsor: Rep. Liz Cheney (R-WY-At-Large)
H.R. 5883 - 116th Congress - Second Session
Generating Effective and Novel Evidence for Therapy Payment Act
Sponsor: Rep. Kurt Schrader (D-OR-05)
H.R. 6649 - 116th Congress - Second Session
Lower Drug Costs for Seniors During COVID-19 Act of 2020
Sponsor: Rep. Jan Schakowsky (D-IL-09)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Extenders; ACA tax credits
H.R.748 - 116th Congress (2019-2020)
Third Coronavirus Stimulus Package (CARES Act)
To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
H.R. 3107 - 116th Congress
Improving Seniors' Timely Access to Care Act of 2019
Sponsor: Rep. Suzan DelBene(D-WA), Rep. Mike Kelly (R-PA), Roger Marshal (R-KS), and Ami Bera (D-CA)
H.R. 6440 - 116th Congress - Second Session
Pandemic Rapid Response Act
Sponsor: Rep. Rodney Davis (R-IL-13)
H.R. 6396 - 116th Congress - Second Session
Responsible Relief for Americans Act
Sponsor: Rep. Andy Biggs (R-AZ-05)
H.R. 6286 - 116th Congress - Second Session
Health Savings Act of 2020
Sponsor: Rep. mike Burgess (R-TX-26)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Opioids; CREATES Act; Drug Pricing
H.R.6193 - 116th Congress
Medication Access in Emergencies Act of 2020
Sponsor: Rep Pappas, Chris [D-NH-1]
H.R.5691 - 116th Congress
Transparency in Prescription Drug Advertising Act
Sponsor: Rep Davids, Sharice [D-KS-3]
H.R. 5894 - 116th Congress - Second Session
Insulin Affordability Data Collection Act
H.R. 5894 - 116th Congress - Second Session
Transparency in Prescription Drug Advertising Act
Sponsor: Rep. Sharice Davids (D-KS-03)
H.R. 5927 - 116th Congress - Second Session
Safe Medicine Act
Sponsor: Rep. Bill Posey (R-FL-08)
H.R. 5663 - 116th Congress - Second Session
Safeguarding Therapeutics Act
Sponsor: Rep Brett Guthrie (R-KY-02)
H.R. 2477 - 116th Congress
Beneficiary Enrollment Notification and Eligibility Simplification Act of 2019
Sponsor: Rep. Raul Ruiz (D-CA-36)
H.R. 5749 - 116th Congress - Second Session
Affordable Insulin for All Act
Sponsor: Rep. Charlie Crist (D-FL-13)
H.R. 6731 - 116th Congress - Second Session
Securing America's Pharmaceutical Supply Chain Act
Sponsor: Rep. Pete Stauber (R-MN-08)
H.R. 5982 - 116th Congress - Second Session
Safe Medicine Act
Sponsor: Rep. Bill Posey (R-FL-08)
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 17, 2020.
Original Filing: 301169702.xml
Lobbying Issues
Affordable Care Act (ACA);Affordability, ACA Regulations; ACA Stabilization; Health Care Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Opioids; Marketplace Stability; Individual Market Reform; Association Health Plans (AHPs); Value-Based Reimbursement; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; CSRs; SNP's; 42 CFR Part 2; Transparency; Silverloading; Interoperability; Health IT; Surprise Billing; Small Business; Biosimilars; Prior Authorization; Provider Directories; Health Reimbursement Arrangements (HRAs); Education and Enrollment; All Payer Claims Databases; Consumer-facing app disclosures; Negotiated Rate Disclosure; Medicare for All; Medicare Buy-In, Texas lawsuit, Transparency, State Flexibility, Social determinants of health, Community Health, Cybersecurity, NBPP(Notice Benefit and Payment Parameters);Consumer-Facing app disclosures; Provider directories; Maternal Health; Senior's health care; COVID-19 Response/Relief Packages; Healthcare access/privacy.
H.R. 1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7](Introduced 2/27/19)
H.R. 2003 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 04/01/2019)
H.R. 2004 - 116th Congress (2019-2020)
Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 04/01/2019)
S. 973 - 116th Congress (2019-2020)
Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act
Sponsor: Sen Smith, Tina [D_MN](Introduced 04/01/2019)
S. 971 - 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Sen. Smith, Tina [D_MN](Introduced 04/01/2019)
S. 1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN](Introduced 6/19/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35](Introduced 02/07/2019)
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr [D-NJ-6](Introduced 07/09/2019)
H.R.3439 - 116th Congress (2019-2020)
PATIENT Act
Sponsor: Rep. Beyer, Donald S.,Jr. [D-VA-8](Introduced 06/24/2019)
S.1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN](Introduced 06/19/2019)
H.R.2774 - 116th Congress (2019-2020)
Primary Care Patient Protection Act of 2019
Sponsor: Rep. Schneider, Brad [D-IL-10](Introduced 05/15/2019)
H.R.5826 - 116th Congress (2019-2020)
Consumer Protections Against Surprise Medical Bills Act of 2020
Sponsor: Rep. Neal, Richard [D-MA-1] (Introduced 02/10/2020)
S.3548 - 116th Congress (2019-2020)
Coronavirus Aid, Relief, and Economic Security Act
Sponsor: Sen. McConnell, Mitch [R-KY](Introduced 03/19/2020)
H.R.5754 - 116th Congress (2019-2020)
Rural ER Access Act
Sponsor: Rep. Green, Mark [R-TN-7](Introduced 02/04/2020)
H.R.5800 - 116th Congress (2019-2020)
Ban Surprise Billing Act
Sponsor: Rep. Scott, Robert [D-VA-3](Introduced 02/07/2020)
H.R.6201 - 116th Congress (2019-2020)
Families First Coronavirus Response Act
Sponsor: Rep. Lowey, Nita [D-NY-17](Introduced 03/11/2020)
H.R.2064 - 116th Congress (2019-2020)
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes
Sponsor: Rep. Chu, Judy [D-CA-27](Introduced 04/03/2020)
H.R.6311 - 116th Congress (2019-2020)
Care for COVID-19 Act
Sponsor: Rep. Ruiz, Raul [D-CA-36](Introduced 03/19/2020)
H.R.6299 - 116th Congress (2019-2020)
Rapid Coverage of COVID-19 Vaccine Act of 2020
Sponsor: Rep. Courtney, joe[D-CT-2](Introduced 03/19/2020)
H.R.5826 - 116th Congress (2019-2020)
Consumer Protections Against Surprise medical Bills Act of 2020
Sponsor: Rep. Neal, Richard [D-MA-1](Introduced 02/10/2020)
H.R.6244 - 116th Congress (2019-2020)
To amend titles XVIII and XIX to provide for coverage at no cost sharing of COVID-19 testing under the Medicaid program and Children's Health Insurance Program.
Sponsor: Rep. Kelly, Robin [D-IL-2](Introduced 03/12/2020)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicaid Rebates; Medicaid Expansion; Medicaid General; Medicare Prior Authorization; MACRA; Rate Notice and Call Letter; NBPP; Medicare Part D Rx Rebates, Medicare Data Sharing; Privacy; Medicare Prescription Drug Pricing; CMS Program Integrity Rule; Generic drugs (CREATES); Drug approval; HELP Cost reduction package; CHIP; Provider funding
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6](Introduced 09/19/2019)
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large](Introduced 01/08/2019)
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 01/10/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits; Cadillac Tax; Health Reimbursement Arrangements (HRA)s; Tax Extenders
H.R.748 - 116th Congress (2019-2020)
Third Coronavirus Stimulus Package (CARES Act)
To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
H.R.1398 -- 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
H.R.2774 - 116th Congress (2019-2020)
Primary Care Patient Protection Act of 2019
Sponsor: Rep Schneider, Brad [D-IL-10](Introduced 05/15/2019)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Rx Rebates; Biosimilars; Drug approval; Drug patents, generic drugs, Part D Reform; Civica Rx
H.R.1499 - 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby [D-IL-1](Introduced 03/08/2019)
H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David [D-RI-1](Introduced 02/05/2019)
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6](Introduced 09/19/2019)
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Action of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large](Introduced 01/08/2019)
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7](Introduced 01/10/2019)
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive Licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35](Introduced 02/07/2019)
S.3092 - 116th Congress (2019-2020)
Expanding Access to Low-Cost Generics Act of 2019
Sponsor: Sen. Smith, Tina [D-MN](Introduced 12/18/2019)
H.R.19 - 116th Congress (2019-2020)
Lower Costs, More Cures Act of 2019
Sponsor: Rep. Walden, Gred [R-OR-2](Introduced 12/09/2019)
H.R.6193 - 116th Congress (2019-2020)
Medication Access in Emergencies Act of 2020
Sponsor: Rep Pappas, Chris [D-NH-1](Introduced 03/11/2020)
H.R.5578 - 116th Congress (2019-2020)
Recall Unsafe Drugs Act of 2020
Sponsor: Rep. Delauro, Rosa [D-CT-3](Introduced 01/10/2020)
H.R.5691 - 116th Congress (2019-2020)
Insulin Affordability Data Collection Act
Sponsor: Rep. Craig, Angie [D-MN-2](Introduced 01/28/2020)
H.R.5894 - 116th Congress (2019-2020)
Transparency in Prescription Drug Advertising Act
Sponsor: Rep Davids, Sharice [D-KS-3](Introduced 02/13/2020)
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 17, 2020.
Original Filing: 301109789.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Care Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Opioids; Marketplace Stability; Individual Market Reform; Sec. 1332 Waivers; Association Health Plans (AHPs); Value-Based Reimbursement; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; CSRs; Transparency; Silverloading; Interoperability; Surprise Billing; Biosimilars; Prior Authorizations; Provider Directories; Health Reimbursement Arrangements (HRAs); Education and Enrollment; All Payer Claims Databases; Consumer-facing app disclosures; Negotiated Rate Disclosure; Medicare for All; Medicare Buy-In, Texas lawsuit, Transparency, State Flexibility, Social determinants of health, Community Health, Cybersecurity, NBPP(Notice Benefit and Payment Parameters)
H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Cost Act
116th Congress (2019-2020)
Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large] (Introduced 02/06/2019)
H.R. 1346 - 116th Congress (2019-2020)
Medicare Buy-in and Health Care Stabilization Act of 2019
Sponsor: Rep. Higgins, Brian[D-NY-26] (Introduced 2/25/19)
H.R. 1384 - 116th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 2/27/19)
H.R. 3502 - 116th Congress (2019-2020)
Protecting People from Surprise Medical Bills Act
Sponsor: Rep. Ruiz, Raul [D-CA-36 (Introduced 6/26/19) (Cosponsors: 48
S. 1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 6/19/2019)
H.R.3630 - 116th Congress (2019-2020)
No Surprises Act
Sponsor: Rep. Pallone, Frank, Jr [D-NJ-6]
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; MACRA; Medicare Part D; Rate Notice and Call Letter; NBPP; Medicare Part D; Part D Donut Hole; Rx Rebates, Medicare Data Sharing; Medicare Prescription Drug Pricing; Privacy; Medicaid Expansion
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Act of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large]
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7]
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits; Cadillac Tax; Health Reimbursement Arrangements (HRA)s; Tax Extenders
S.172 -- 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Sen. Gardner, Cory [R-CO] (Introduced 01/16/2019)
S.684 -- 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Sen. Heinrich, Martin [D-NM] (Introduced 03/06/2019)
H.R.748 -- 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Rep. Courtney, Joe [D-CT-2] (Introduced 01/24/2019)
H.R.1398 -- 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Rx Rebates; Biosimilars; Drug approval; Drug patents, generic drugs, Part D Reform
H.R.1781 -- 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
H.R.938 - 116th Congress (2019-2020)
BLOCKING Act of 2019
Sponsor: Rep. Schrader, Kurt [D-OR-5]
H.R.1520 - 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18]
H.R.1503 - 116th Congress (2019-2020)
Orange Book Transparency Act of 2019
Sponsor: Rep. Kelly, Robin L. [D-IL-2]
H.R.1499 - 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1]
H.R.965 - 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1]
H.R.3 - 116th Congress (2019-2020)
Lower Drug Costs Now Act of 2019
Sponsor: Rep. Pallone, Frank, Jr. [D-NJ-6]
H.R.275 - 116th Congress (2019-2020)
Medicare Prescription Drug Price Negotiation Action of 2019
Sponsor: Rep. Welch, Peter [D-VT-At Large]
H.R.448 - 116th Congress (2019-2020)
Medicare Drug Price Negotiation Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7]
H.R.1046 - 116th Congress (2019-2020)
Medicare Negotiation and Competitive licensing Act of 2019
Sponsor: Rep. Doggett, Lloyd [D-TX-35]
S.3092 - 116th Congress (2019-2020)
Expanding Access to Low-Cost Generics Act of 2019
Sponsor: Sen. Tina Smith (D-MN)
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 17, 2019.
Original Filing: 301067853.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Care Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Opioids; Marketplace Stability; Individual Market Reform; Sec. 1332 Waivers; Association Health Plans (AHPs); Value-Based Reimbursement; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; CSRs; Transparency; Silverloading; Interoperability; Surprise Billing; Biosimilars; Prior Authorizations; Provider Directories; Health Reimbursement Arrangements (HRAs); Education and Enrollment; All Payer Claims Databases; Consumer-facing app disclosures; Negotiated Rate Disclosure; Medicare for All; Medicare Buy-In
H.R. 987 - Strengthening Health Care and Lowering Prescription Drug Cost Act
116th Congress (2019-2020)
Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large] (Introduced 02/06/2019)
H.R. 1346 - 116th Congress (2019-2020)
Medicare Buy-in and Health Care Stabilization Act of 2019
Sponsor: Rep. Higgins, Brian[D-NY-26] (Introduced 2/25/19)
H.R. 1384 - 11th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 2/27/19)
H.R. 3502 - 116th Congress (2019-2020)
Protecting People from Surprise Medical Bills Act
Sponsor: Rep. Ruiz, Raul [D-CA-36 (Introduced 6/26/19) (Cosponsors: 48
S. 1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 6/19/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; MACRA; Medicare Part D; Rate Notice and Call Letter; NBPP; Medicare Part D; Part D Donut Hole; Rx Rebates, Medicare Data Sharing; Medicare Prescription Drug Pricing; Privacy
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits; Cadillac Tax; Health Reimbursement Arrangements (HRA)s
S.172 -- 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Sen. Gardner, Cory [R-CO] (Introduced 01/16/2019)
S.684 -- 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Sen. Heinrich, Martin [D-NM] (Introduced 03/06/2019)
H.R.748 -- 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Rep. Courtney, Joe [D-CT-2] (Introduced 01/24/2019)
H.R.1398 -- 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Rx Rebates; Biosimilars
H.R. 1781 -- 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
H.R. 938 -- 116th Congress (2019-2020)
BLOCKING Act of 2019
Sponsor: Rep. Schrader, Kurt [D-OR-5]
H.R.1520 -- 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18]
H.R. 1503 -- 116th Congress (2019-2020)
Orange Book Transparency Act of 2019
Sponsor: Rep. Kelly, Robin L. [D-IL-2]
H.R. 1499 -- 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1]
H.R. 965 -- 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1]
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 22, 2019.
Original Filing: 301058715.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Care Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Marketplace Stability; Individual Market Reform; Sec. 1332 Waivers; Short Term Limited Duration Plans (STLDP); Association Health Plans (AHPs); CREATES Act; Value-Based Reimbursement; Health Care Costs; Mental Health; Small Business Plans; Reinsurance; CSRs; Transparency; Silverloading; Interoperability; Surprise Billing; Biosimilars; Prior Authorizations; Provider Directories; Health Reimbursement Arrangements (HRAs); Education and Enrollment; All Payer Claims Databases; Negotiated Rate Disclosure; Medicare for All; Medicare Buy-In
H.R. 1346 - 116th Congress (2019-2020)
Medicare Buy-in and Health Care Stabilization Act of 2019
Sponsor: Rep. Higgins, Brian[D-NY-26] (Introduced 2/25/19)
H.R. 1384 - 11th Congress (2019-2020)
Medicare for All Act of 2019
Sponsor: Rep. Jayapal, Pramila [D-WA-7] (Introduced 2/27/19)
H.R. 3502 - 116th Congress (2019-2020)
Protecting People from Surprise Medical Bills Act
Sponsor: Rep. Ruiz, Raul [D-CA-36 (Introduced 6/26/19) (Cosponsors: 48
S. 1895 - 116th Congress (2019-2020)
Lower Health Care Costs Act
Sponsor: Sen. Alexander, Lamar [R-TN] (Introduced 6/19/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; CHIP Reform; MACRA; Medicare Part D; Rate Notice and Call Letter; NBPP; Part D Donut Hole; Rx Rebates, Medicare Data Sharing; Privacy
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits; Cadillac Tax; Health Reimbursement Arrangements (HRA)s
S.172 -- 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Sen. Gardner, Cory [R-CO] (Introduced 01/16/2019)
S.684 -- 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Sen. Heinrich, Martin [D-NM] (Introduced 03/06/2019)
H.R.748 -- 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Rep. Courtney, Joe [D-CT-2] (Introduced 01/24/2019)
H.R.1398 -- 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Rx Rebates; Biosimilars
H.R. 1781 -- 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
H.R. 938 -- 116th Congress (2019-2020)
BLOCKING Act of 2019
Sponsor: Rep. Schrader, Kurt [D-OR-5]
H.R.1520 -- 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18]
H.R. 1503 -- 116th Congress (2019-2020)
Orange Book Transparency Act of 2019
Sponsor: Rep. Kelly, Robin L. [D-IL-2]
H.R. 1499 -- 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1]
H.R. 965 -- 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1]
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 22, 2019.
Original Filing: 301037186.xml
Lobbying Issues
Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs RX Rebates; RX Rebates
H.R. 1781 -- 116th Congress (2019-2020)
Payment Commission Data Act of 2019
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1]
H.R. 938 -- 116th Congress (2019-2020)
BLOCKING Act of 2019
Sponsor: Rep. Schrader, Kurt [D-OR-5]
H.R.1520 -- 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18]
H.R. 1503 -- 116th Congress (2019-2020)
Orange Book Transparency Act of 2019
Sponsor: Rep. Kelly, Robin L. [D-IL-2]
H.R. 1499 -- 116th Congress (2019-2020)
Protecting Consumer Access to Generic Drugs Act of 2019
Sponsor: Rep. Rush, Bobby L. [D-IL-1]
H.R. 965 -- 116th Congress (2019-2020)
CREATES Act of 2019
Sponsor: Rep. Cicilline, David N. [D-RI-1]
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Opioids; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Mental Health, Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; FEHBP Issues; 42 CFR Part 2; Transparency; Silverloading; Health IT; Interoperability; Urban Affairs/ Deterrence (Opioid epidemic); Texas lawsuit; Surprise Billing, Transparency, Small Business, State Flexibility; Biosimilars; Provider Directories; Postal Reform; Health Reimbursement Arrangements (HRAs)
H.R.2003 -- 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019)
H.R.2004 -- 116th Congress (2019-2020)
Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act
Sponsor: Rep. Cummings, Elijah E. [D-MD-7] (Introduced 04/01/2019)
S.973 -- 116th Congress (2019-2020)
Ensuring FEDVIP and FLTCIP Coverage During Shutdowns Act
Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019)
S.971 -- 116th Congress (2019-2020)
Ensuring FEHBP Coverage During Shutdowns Act
Sponsor: Sen. Smith, Tina [D-MN] (Introduced 04/01/2019)
H.R.1385 -- 116th Congress (2019-2020)
SAVE Act
Sponsor: Rep. Kim, Andy [D-NJ-3] (Introduced 02/27/2019)
H.R.1386 -- 116th Congress (2019-2020)
ENROLL Act of 2019
Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/27/2019)
H.R.987 -- 116th Congress (2019-2020)
MORE Health Education Act
Sponsor: Rep. Blunt Rochester, Lisa [D-DE-At Large]
H.R.1010 -- 116th Congress (2019-2020)
To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect.
Sponsor: Rep. Castor, Kathy [D-FL-14] (Introduced 02/06/2019)
H.R.986 -- 116th Congress (2019-2020)
Protecting Americans with Preexisting Conditions Act of 2019
Sponsor: Rep Kuster, Ann M. [D-NH-2] (Introduced 02/06/2019)
H.R.1425 -- 116th Congress (2019-2020)
State Health Care Premium Reduction Act
Sponsor: Rep. Craig, Angie [D-MN-2] (Introduced 02/28/2019)
H.R.1143 -- 116th Congress (2019-2020)
Educating Consumers on the Risks of Short-Term Plans Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 02/11/2019)
H.R.1520 -- 116th Congress (2019-2020)
Purple Book Continuity Act of 2019
Sponsor: Rep. Eshoo, Anna G. [D-CA-18] (Introduced 03/05/2019)
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; CHIP Reform; MACRA; Medicare Part D; NBPP; RX Rebates
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits; Cadillac Tax; Health Reimbursement Arrangements (HRA)s
S.172 -- 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Sen. Gardner, Cory [R-CO] (Introduced 01/16/2019)
S.684 -- 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Sen. Heinrich, Martin [D-NM] (Introduced 03/06/2019)
H.R.748 -- 116th Congress (2019-2020)
Middle Class Health Benefits Tax Repeal Act of 2019
Sponsor: Rep. Courtney, Joe [D-CT-2] (Introduced 01/24/2019)
H.R.1398 -- 116th Congress (2019-2020)
Health Insurance Tax Relief Act of 2019
Sponsor: Rep. Bera, Ami [D-CA-7] (Introduced 02/27/2019)
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2018
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 18, 2019.
Original Filing: 301009284.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Opioids; Marketplace Stability; Individual Market Reform; FAA (Air Ambulance); CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD); AHPs; Value-Based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; SNPs; Health Savings Accounts (HSAs); 42 CFR Part 2; Transparency; Silverloading; Texas Lawsuit; Air Ambulance; Surprise Billing
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 2051 FAST Generics Act Introduced April 6, 2017 by David McKinley (R-WV) To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.
HR 2212 CREATES Act Introduced April 27, 2017 by Tom Marino (R-PA) To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
HR 6733 Know the Cost Act of 2018 Introduced September 7, 2018 by Buddy Carter (R-GA) To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act; Drug Pricing; PBM/Prescription Drug Costs RX Rebates; Direct-to-Consumer Rx Advertising; Rx Rebates
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; Medicare Prior Authorization; Medicaid Expansion; Medicaid General; CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Rate Notice and Call Letter; Medicare Part D; NBPP, Part D Donut Hole, Rx Rebates, Patient's Act (Dialysis)
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 4143 Dialysis Patients Demonstration Act of 2017 Introduced October 26, 2017 by Jason Smith (R-MO) To establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes.
HR 6478 Biosimilars Competition Act of 2018 Introduced July 23, 2018 by John Sarbanes (D-MD) To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding biologic and biosimilar products, and for other purposes.
S 2554 Patient Right to Know Drug Price Act of 2018 Introduced March 14, 2018 by Susan Collins (R-ME) Americans overspend by an estimated $135 million on prescriptions through their insurance, in cases when they would cost less out of pocket. Yet pharmacists are often under gag orders from telling customers about that discrepancy. A new bill introduced in the Senate would end this practice.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits; Cadillac Tax
HR 173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2-17 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
S 3063 Introduced June 13, 2018 by John Barrasso (R-WY) A bill to delay the reimposition of the annual fee on health insurance providers until after 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2018
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 17, 2018.
Original Filing: 300987789.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Rural Healthcare; Risk Adjustment; State Flexibility; Opioids; Marketplace Stability; Individual Market Reform; FAA (Air Ambulance); CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD); AHPs; Value-Based Care; Health Care Costs; Mental Health; Small Business Plans; Single Payer; Reinsurance; CSRs; Health Savings Accounts (HSAs); Postal Reform; 42 CFR Part 2; Transparency
HR 4 FAA Reauthorization Act of 2018 Introduced April 13, 2018 by Bill Shuster (R-PA) Air Ambulance
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 6082 Overdose Prevention and Patient Safety Act Introduced June 13, 2018 by Markwayne Mullin (R-OK) Amends the Public Health Service Act to permit substance use disorder (SUD) records to be shared among covered entities and Part 2 programs in accordance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA), for the purposes of treatment, payment, and healthcare operations. In order to protect individuals seeking and receiving SUD treatment, the bill enhances the protections on the disclosure of SUD treatment records to non-covered entities and non-part 2 programs by, except for authorization by court order or by consent of the patient, prohibiting the use of these records in any criminal, civil, or administrative investigations, actions, or proceedings. The legislation increases the penalties in the event of unlawful disclosure of SUD treatment records and establishes breach notification requirements in accordance with the Health Information Technology for Economic and Clinical Health (HITECH) Act. Finally, the bill requires the Secretary of Health and Human Services to issue regulations prohibiting discrimination based on data disclosed from such medical records, to issue regulations requiring covered entities to provide written notice of privacy practices, and to develop model training programs and materials for health care providers and patients and their families.
S 1354 Individual Health Insurance Marketplace Improvement Act introduced June 14, 2017 by Thomas Carper (D-DE) A bill to establish an Individual Market Reinsurance fund to provide funding for State individual market stabilization reinsurance programs.
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits
HR 173 Middle Class Health BEnefit Tax Repeal Act Introduced January 3, 2-17 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 5963 Introduced May 24, 2018 by Kristi Noem (R-SD) To delay the reimposition of the annual fee on health insurance providers until after 2020.
S 3063 Introduced June 13, 2018 by John Barrasso (R-WY) A bill to delay the reimposition of the annual fee on health insurance providers until after 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2018
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 21, 2018.
Original Filing: 300978871.xml
Lobbying Issues
Affordable Care Act (ACA); ACA Regulations; Opioid Epidemic; ACA Stabilization; Health Savings Accounts (HSAs); Postal Reform; Cost Sharing Reductions (CSRs); Health Care Reform Reinsurance; Market Stability; State Flexibility; Pay-fors; Affordability; 1332 Templates; Healthcare Innovation; Risk Adjustment; Department Reform; Drug Pricing; Association Health Plans; Short Term Limited Duration; Air Ambulances; 42 CFR Part 2; Individual Market Reform; CREATES Act; Marketplace Certainty Act; Individual Market Rules; Small Group Market; Rural Health; Health Information Technology
HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 314 Introduced January 5, 2017 by Marsha Blackburn (R-TN) To repeal Title I of the Patient Protection and Affordable Care Act and to amend the Public Health Service Act to provide for cooperative governing of individual health insurance coverage offered in interstate commerce.
HR 1703 Introduced March 23, 2017 by Morgan Griffith (R-VA) To amend the Federal Food, Drug, and Cosmetic Act with respect to determining the intended use of drugs and devices.
HR 2051 FAST Generics Act Introduced April 6, 2017 by David McKinley (R-WV) To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.
HR 2430 Introduced May 10, 2017 by Greg Walden (R-OR) To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
HR 2026 Pharmaceutical Information Exchange Act Introduced April 6, 2017 by Brett Guthrie (R-VA) To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers.
HR 1101 Small Business Health Fairness Act of 2017 Introduced February 16, 2017 by Sam Johnson (R-TX) To amend Title I of the Employee Retirement Income Security Act of 1974 to improve access and choice for entrepreneurs with small businesses with respect to medical care for their employees.
HR 2400 Introduced May 8, 2017 by Darrell Issa (R-CA) To amend Title 5, United States Code, to allow individuals who are not Federal employees to enroll in the Federal Employees Health Benefits Program, and for other purposes.
HR 708 Introduced January 27, 2017 by Larry Bucshon (R-IN) This bill amends the Public Health Service Act to increase the permissible variation based on age for health insurance premiums for coverage offered in the individual or small group market from a factor of three to a factor of five, or to a factor determined by the state. This applies to plan years starting on or after January 1, 2018.
HR 2051 Fast Generics Act of 2017 Introduced April 6, 2017 by David McKinley (R-VA) To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.
HR 2889 Closing Loopholes for Orphan Drugs Act Introduced June 13, 2017 by Peter Welch (D-VT) To amend Title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title.
HR 2212 CREATES Act Introduced April 27, 2017 by Tom Marino (R-PA) To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
HR 1409 Cancer Drug Parity Act of 2017 Introduced by Leonard Lance (R-NJ) To amend the Public Health Service Act to require group and individual health insurance coverage and group health plans to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.
HR 749 Lower Drug Cost Through Competition Act Introduced January 30, 2017 by Kurt Schrader (D-OR) To increase competition in the pharmaceutical industry.
HR 4666 Premium Relief Act Introduced December 18, 2017 by Ryan Costello (R-PA) To amend the Public Health Service Act to provide for a Patient and State Stability Fund.
HR 3976 Access to Marketplace Insurance Act Introduced October 5, 2017 by Kevin Cramer (R-ND) To amend the Patient Protection and Affordable Care Act to allow for certain third-party payments.
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 5228 SCREEN Act Introduced March 8, 2018 by Frank Pallone, Jr. (D-NJ) H.R. 5228 will provide the Food and Drug Administration (FDA) with stronger recall and seizure authority to disrupt the entry of counterfeit and illicit drugs through International Mail Facilities (IMFs).
HR 5752 Stop Illicit Drug Importation Act of 2018 Introduced May 10, 2018 by Marsha Blackburn (R-TN) amends the Federal Food, Drug, and Cosmetic Act (FD&C) to strengthen the Food and Drug Administration's (FDA) seizure powers and enhance its authority to detain, refuse, seize, or destroy illegal products offered for import. The legislation would subject more people to debarment and civil penalties under the Act.
HR 5806 21st Century Tools for Pain and Addiction Treatment Act Introduced May 15, 2018 by Michael Burgess (R-TX) To require the Secretary of Health and Human Services to issue guidance with respect to the expedited approval of certain drugs, and for other purposes.
HR 4998 Health Insurance for Former Foster Youth Act Introduced February 13, 2018 by Karen Bass (D-CA) To amend Title XIX of the Social Security Act to ensure health insurance coverage continuity for former foster youth.
HR 5801 Medicaid Providers Are Required To Note Experiences in Record Systems to Help In-need Patients Act Introduced May 15, 2018 by Morgan Griffith (R-VA) To amend Title XIX of the Social Security Act to provide for requirements under the Medicaid program relating to the use of qualified prescription drug monitoring programs and prescribing certain controlled substances.
HR 5715 Strengthening Partnerships to Avoid Opioid Abuse Act Introduced May 9, 2018 by James Renacci (R-OH) To amend Title XVIII of the Social Security Act to provide for certain program integrity transparency measures under Medicare Parts C and D.
HR 5716 COMPASS Act Introduced May 9, 2018 by Peter Roskam (R-IL) To amend Title XVIII of the Social Security Act to provide for certain program integrity transparency measures under Medicare Parts C and D.
HR 5796 Responsible Education Achieves Care and Healthy Outcomes for Users' Treatment Act of 2018 Introduced May 15, 2018 by Brian Fitzpatrick (R-PA) To require the Secretary of Health and Human Services to provide grants for eligible entities to provide technical assistance to outlier prescribers of opioids, and for other purposes.
HR 5590 Opioid Addiction Action Plan Act Introduced April 24, 2018 by Adam Kinzinger (R-IL) To require the Secretary of Health and Human Services to provide for an action plan on recommendations for changes under Medicare and Medicaid to prevent opioids addictions and enhance access to medication-assisted treatment, and for other purposes.
HR 5603 Access to Telehealth Services for Substance Use Disorders Act Introduced April 24, 2018 by Doris Matsui (D-CA) To amend Title XVIIII of the Social Security Act to provide the Secretary of Health and Human Services authority to waive certain Medicare telehealth requirements in the case of certain treatment of an opioid use disorder or co-occurring mental health disorder.
HR 5605 Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act Introduced April 24, 2018 by Raul Ruiz (D-CA) establishes a four-year demonstration program to increase access to treatment for opioid use disorder. The demonstration would provide incentive payments and funding for care management services based on criteria such as patient engagement, use of evidence-based treatments, and treatment length and intensity. Under the bill, the Secretary of Health and Human Services would be directed to encourage other payers to coordinate payments for opioid use disorder treatments and to evaluate the extend to which the demonstration reduces hospitalizations, increases the use of medication-assisted treatments, and improves the health outcomes of individuals with opioid use disorders during and after the demonstration. This bill also incorporates H.R. 3528, Every Prescription Conveyed Securely Act, which would require e-prescribing, with exceptions, for coverage of prescribed controlled substances under the Medicare Part D program.
HR 5798 Opioid Screening and Chronic Pain Management Alternatives for Seniors Act Introduced May 15, 2018 by Larry Bucshon (R-IN) To amend Title XVIII of the Social Security Act to require a review of current opioid prescriptions for chronic pain and screening for opioid use disorder to be included in the Welcome to Medicare initial preventive physical examinations.
HR 4684 Ensuring Access to Quality Sober Living Act of 2018 Introduced December 19, 2017 by Judy Chu (D-CA) Authorizes the Substance Abuse and Mental Health Services Administration to develop, publish, and disseminate best practices for operating recovery housing that promotes a safe environment and sustained recovery from substance use disorders.
Recovery housing is increasingly recognized as critical to recovery for many individuals, and includes activities and programs such as mediation, one-on-one counseling, group sessions, peer recovery support, medication management, spiritual engagement, and others.
HR 5329 Poison Center Network Enhancement Act of 2018 Introduced March 19, 2018 by Susan Brooks (D-IN) reauthorizes the national network of Poison Control Centers. Specifically, the legislation reauthorizes the toll-free number, national media campaign, and grant program under the Public Health Service Act. The legislation increases the share of poison control center funding that could be provided through federal grants, and authorizes $30 million per year over the 2019-2023 period.
HR 5580 STOP Fentanyl Deaths Act of 2018 Introduced April 23, 2018 by Ann Kuster (D-NH) To authorize the Secretary of Health and Human Services to conduct programs to address the usage of illicit drugs, particularly fentanyl, and for other purposes.
HR 5587 Peer Support Communities of Recovery Act Introduced April 23, 2018 by Ben Lujan (D-NM) enhances the Comprehensive Addiction and Recovery Act's Building Communities of Recovery Program and authorizes the Department of Health and Human Services (HHS) to award grants to peer support specialist organizations for the development and expansion of recovery services. Grants shall be awarded to nonprofit organizations that support community-based, peer delivered support, including technical support for the establishment of recovery community organizations, independent, nonprofit groups led by people in recovery and their families.
HR 5804 Post-Surgical Injections as an Opioid Alternative Act Introduced May 15, 2018 by John Shimkus (R-IL) To amend Title XVIII of the Social Security Act to provide for modifications in payment for certain outpatient surgical services.
HR 5809 Postoperative Opioid Prevention Act of 2018 Introduced May 15, 2018 by Scott Peters (D-CA) To amend Title XVIII of the Social Security Act to encourage the use of non-opioid analgesics for the management of post-surgical pain under the Medicare program, and for other purposes.
HR 5795 Overdose Prevention and Patient Safety Act Introduced May 15, 2018 by Earl Blumenauer (D-OR) To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records.
HR 5812 Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2018 Introduced May 15, 2018 by Morgan Griffith (R-VA) Will authorize the Centers for Disease Control and Prevention to carry out certain controlled substances overdose prevention and surveillance activities in order to improve data collection and integration into physician clinical workflow so that timely, complete, and accurate information will get into the hands of providers and dispensers so that they can make the best clinical decisions for their patients.
HR 449 Synthetic Drug Awareness Act of 2018 Introduced January 11, 2017 by Hakeem Jeffries (D-NY) requires the U.S. Surgeon General to report to Congress on the public health effects of the rise in synthetic drug use among youth aged 12 to 18 years old in order to further educate parents and the medical community on the health effects of synthetics.
HR 4284 INFO Act Introduced November 7, 2017 by Robert Latta (R-OH) directs the Department of Health and Human Services (HHS) to create a public and easily accessible electronic dashboard linking to all of the nationwide efforts to combat the opioid crisis. In addition, the legislation creates an Interagency Substance Use Disorder Coordinating Committee to review and coordinate opioid use disorder (OUD) and other substance use disorder (SUD) research, services, and prevention activities across all relevant Federal agencies, evaluate the effectiveness of these activities, and make specific recommendations for actions that agencies can take to better coordinate the administration of services for patients with OUD and SUD.
HR 5002 Advancing Cutting Edge Research Act Introduced February 18, 2018 by Debbie Dingell (D-MI) Provides the National Institutes of Health new authorities to conduct research on innovative non-addictive pain medications.
HR 5102 Substance Use Disorder Workforce Loan Repayment Act of 2018 Introduced February 27, 2018 by Katherine Clark (D-MA) creates a loan repayment program for substance use disorder (SUD) treatment providers. Specifically, the legislation offers student loan repayment of up to $250,000 for participants who agree to work as a SUD treatment professional in areas most in need of their services. The program is available to a wide range of direct care providers, including physicians, registered nurses, social workers, and other behavioral health professionals. The bill authorizes $25 million a year for the 2019-2028 period.
HR 5009 Jessie's Law Introduced February 13, 2018 by Tim Walberg (R-MI) Ensures medical professionals have access to a consenting patient's complete health information when making treatment decisions by requirement the Department of Health and Human Services (HHS) to develop and annually disseminate best practices regarding the prominent display of substance use disorder (SUD) history in records of patients who have previously provided this information to a health care provider.
HR 5176 Preventing Overdoses While in Emergency Room Act of 2018 Introduced March 6, 2018 by David McKinley (R-VA) requires the Secretary of the Department of Health and Human Services (HHS) to develop protocols and a grant program for health care providers to address the needs of people who survive a drug overdose. Specifically, the protocols would address the provision of naloxone upon discharge, connection with peer-support specialists, and the referral to treatment and other services that best fit the patient's needs. The bill authorizes $50 million in FY 2019 for the grant program.
HR 5197 ALTO Act Introduced March 7, 2018 by Bill Pascrell, Jr. (D-NJ) Directs the Secretary of Health and Human Services (HHS) to carry out a demonstration program to test alternative pain management protocols to limit the use of opioids in hospital emergency departments. Following the completion of the three-year demonstration, the Secretary of Health and Human Services will submit a report to Congress on the results of the program and issue recommendations for broader implementation. The legislation authorizes $10 million annually in grants for fiscal years 2019-2021.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Opioid Epidemic; Drug Pricing; PBM/Prescription Drug Costs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Advantage; CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Rate Notice and Call Letter; Medicaid; Opioids; Air Ambulance; Medicare Part D
HR 2575 Introduced May 19, 2017 by Raul Ruiz (R-CA) To amend title XVIII of the Social Security Act to establish a system to educate individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes.
HR 3780 Air Ambulance Quality and Accountability Act Introduced September 14, 2017 by Richard Hudson (R-NC) To amend title XVIII of the Social Security Act to provide under the Medicare program for conditions of participation, reporting requirements, and a quality program with respect to air
ambulance services.
HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee.
HR 5228 SCREEN Act Introduced March 8, 2018 by Frank Pallone, Jr. (D-NJ) H.R. 5228 will provide the Food and Drug Administration (FDA) with stronger recall and seizure authority to disrupt the entry of counterfeit and illicit drugs through International Mail Facilities (IMFs).
HR 5752 Stop Illicit Drug Importation Act of 2018 Introduced May 10, 2018 by Marsha Blackburn (R-TN) amends the Federal Food, Drug, and Cosmetic Act (FD&C) to strengthen the Food and Drug Administrations (FDA) seizure powers and enhance its authority to detain, refuse, seize, or destroy illegal products offered for import. The legislation would subject more people to debarment and civil penalties under the Act.
HR 5806 21st Century Tools for Pain and Addiction Treatment Act Introduced May 15, 2018 by Michael Burgess(R-TX) To require the Secretary of Health and Human Services to issue guidance with respect to the expedited approval of certain drugs, and for other purposes.
HR 5811 Long-Term Opioid Efficacy Act of 2018 Introduced May 15, 2018 by Jerry McNerney (D-CA) To amend the Federal Food, Drug, and Cosmetic Act with respect to post-approval study requirements for certain controlled substances, and for other purposes.
HR 5789 Introduced May 15, 2018 by Bill Foster (D-IL) To amend title XIX of the Social Security Act to provide for Medicaid coverage protections for pregnant and postpartum women while receiving inpatient treatment for a substance use disorder, and for other purposes.
HR 5715 Strengthening Partnerships to Avoid Opioid Abuse Act Introduced May 9, 2018 by James Renacci (R-OH) To amend title XVIII of the Social Security Act to provide for certain program integrity transparency measures under Medicare parts C and D.
HR 5716 COMPASS Act Introduced May 9, 2018 by Peter Roskam (R-IL) To amend title XVIII of the Social Security Act to provide for certain program integrity transparency measures under Medicare parts C and D.
HR 5796 Responsible Education Achieves Care and Healthy Outcomes for Users Treatment Act of 2018 Introduced May 15, 2018 by Brian Fitzpatrick (R-PA) To require the Secretary of Health and Human Services to provide grants for eligible entities to provide technical assistance to outlier prescribers of opioids, and for other purposes.
HR 5590 Opioid Addiction Action Plan Act Introduced April 24, 2018 by Adam Kinzinger (R-IL) To require the Secretary of Health and Human Services to provide for an action plan on recommendations for changes under Medicare and Medicaid to prevent opioids addictions and enhance access to
medication-assisted treatment, and for other purposes.
HR 5605 Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act Introduced April 24, 2018 by Raul Ruiz (D-CA) establishes a four-year demonstration program to increase access to treatment for opioid use disorder. The demonstration would provide incentive payments and funding
for care management services based on criteria such as patient engagement, use of evidence-based treatments, and treatment length and intensity. Under the bill, the Secretary of Health and Human Services would be directed to encourage other payers to coordinate payments for opioid use disorder treatments and to evaluate the extent to which the demonstration reduces hospitalizations, increases the use of medication-assisted treatments, and improves the health outcomes of individuals with opioid use disorders during and after the demonstration. This bill also incorporates H.R. 3528, Every Prescription Conveyed Securely Act, which would require e-prescribing, with exceptions, for coverage of prescribed controlled substances under the Medicare Part D program.
HR 5798 Opioid Screening and Chronic Pain Management Alternatives for Seniors Act Introduced May 15, 2018 by Larry Bucshon (R-IN) To amend title XVIII of the Social Security Act to require a review of current opioid prescriptions for chronic pain and screening for opioid use disorder to be included in the Welcome to Medicare initial preventive physical examination.
HR 4684 Ensuring Access to Quality Sober Living Act of 2018 Introduced December 19, 2017 by Judy Chu (D-CA) Authorizes the Substance Abuse and Mental Health Services Administration to develop, publish, and disseminate best practices for operating recovery housing that promotes a safe environment and sustained recovery from substance use disorders. Recovery housing is increasingly recognized as critical to recovery for many individuals, and includes activities and programs such as mediation, one-on-one counseling, group sessions, peer recovery support, medication management, spiritual engagement, and others.
HR 5329 Poison Center Network Enhancement Act of 2018 Introduced March 19, 2018 by Susan Brooks (D-IN) reauthorizes the national network of Poison Control Centers. Specifically, the legislation reauthorizes the toll-free number, national media campaign, and grant program under the Public Health Service Act. The legislation increases the share of poison control center funding that could be provided through federal grants, and authorizes $30 million per year over the 2019-2023 period.
HR 5580 STOP Fentanyl Deaths Act of 2018 Introduced April 23, 2018 by Ann Kuster (D-NH) To authorize the Secretary of Health and Human Services to conduct programs to address the usage of illicit drugs, particularly fentanyl, and for other purposes.
HR 5587 Peer Support Communities of Recovery Act Introduced April 23, 2018 by Ben Lujan (D-NM) enhances the Comprehensive Addiction and Recovery Acts Building Communities of Recovery Program and authorizes the Department of Health and Human Services (HHS) to award grants to peer support specialist organizations for the development and expansion of recovery services. Grants shall be awarded to nonprofit organizations that support community-based, peer delivered support, including technical support for the establishment of recovery community organizations, independent, nonprofit
groups led by people in recovery and their families.
HR 5804 Post-Surgical Injections as an Opioid Alternative Act Introduced May 15, 2018 by John Shimkus (R-IL) To amend title XVIII of the Social Security Act to provide for modifications in payment for certain outpatient surgical services.
HR 5795 Overdose Prevention and Patient Safety Act Introduced May 15, 2018 by Earl Blumenauer (D-OR) To amend the Public Health Service Act to protect the confidentiality of substance use disorder patient records.
HR 5812 Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2018 Introduced May 15, 2018 by Morgan Griffith (R-VA) Will authorize the Centers for Disease Control and Prevention to carry out certain controlled substances overdose
prevention and surveillance activities in order to improve data collection and integration into physician clinical workflow so that timely, complete, and accurate information will get into the hands of providers and dispensers so that they can make the best clinical decisions for their patients.
HR 449 Synthetic Drug Awareness Act of 2018 Introduced January 11, 2017 by Hakeem Jeffries (D-NY) requires the U.S. Surgeon General to report to Congress on the public health effects of the rise in synthetic drug use among youth aged 12 to 18 years old in order to further educate parents and the
medical community on the health effects of synthetics.
HR 4284 INFO Act Introduced November 7, 2017 by Robert Latta (R-OH) directs the Department of Health and Human Services (HHS) to create a public and easily accessible electronic dashboard linking to all of the nationwide efforts to combat the opioid crisis. In addition, the legislation creates an Interagency Substance Use Disorder Coordinating Committee to review and coordinate opioid use disorder (OUD) and other substance use disorder (SUD) research, services, and prevention activities across all relevant Federal agencies, evaluate the effectiveness of these activities, and make specific recommendations for actions that agencies can take to better coordinates the administration of services for patients with OUD and SUD.
HR 5002 Advancing Cutting Edge Research Act Introduced February 18, 2018 by Debbie Dingell (D-MI) Provides the National Institutes of Health new authorities to conduct research on innovative non-addictive pain medications.
HR 5102 Substance Use Disorder Workforce Loan Repayment Act of 2018 Introduced February 27, 2018 by Katherine Clark (D-MA) creates a loan repayment program for substance use disorder (SUD) treatment providers. Specifically, the legislation offers student loan repayment of up to $250,000 for
participants who agree to work as a SUD treatment professional in areas most in need of their services. The program is available to a wide range of direct care providers, including physicians, registered nurses, social workers, and other behavioral health professionals. The bill authorizes $25 million a year for the 2019-2028 period.
HR 5009 Jessies Law Introduced February 13, 2018 by Tim Walberg (R-MI) Ensures medical professionals have access to a consenting patients complete health information when making treatment decisions by requiring the Department of Health and Human Services (HHS) to develop and annually disseminate best practices regarding the prominent display of substance use disorder (SUD) history in records of patients who have previously provided this information to a health care provider.
HR 5176 Preventing Overdoses While in Emergency Rooms Act of 2018 Introduced March 6, 2018 by David McKinley (R-VA) requires the Secretary of the Department of Health and Human Services (HHS) to develop protocols and a grant program for health care providers to address the needs of people
who survive a drug overdose. Specifically, the protocols would address the provision of naloxone upon discharge, connection with peer-support specialists, and the referral to treatment and other services that best fit the patients needs. The bill authorizes $50 million in FY2019 for the grant program.
HR 5197 ALTO Act Introduced March 7, 2018 by Bill Pascrell, Jr. (D-NJ) Directs the Secretary of Health and Human Services (HHS) to carry out a demonstration program to test alternative pain management protocols to limit the use of opioids in hospital emergency departments. Following the
completion of the three-year demonstration, the Secretary of Health and Human Services will submit a report to Congress on the results of the program and issue recommendations for broader implementation. The legislation authorizes $10 million annually in grants for fiscal years 2019-2021.
HR 5261 Treatment, Education, and Community Help to Combat Addiction Act of 2018 Introduced March 13, 2018 by Bill Johnson (R-OH) directs the Secretary of Health and Human Services (HHS) to designate regional Centers of Excellence to enhance and improve how health professional are educated in substance abuse disorder prevention, treatment, and recovery through development, evaluation, and distribution of evidence-based curricula for health profession schools. The bill authorizes $4 million annually for grants to those programs over the 2019-2023 period.
HR 5272 To provide additional guidance to grantees seeking funding to treat or prevent mental health or substance use disorders. Introduced March 14, 2018 by Steve Stivers (R-OH) Requires the newly established National Mental Health and Substance Use Policy Laboratory to issue guidance to applicants for Substance Abuse and Mental Health Services Administration (SAMHSA) grants that support evidence-based practices. The guidance shall include how best to articulate the rationale for a given program or activity; encourage the funding of evidence-based interventions; and encourage the replication of promising or effective practices.
HR 5327 Comprehensive Opioid Recovery Centers Act of 2018 Introduced March 19, 2018 by Brett Guthrie (R-KY) directs the Secretary of Health and Human Services (HHS) to award grants to at least 10 providers that offer treatment services for people with opioid use disorder. These Comprehensive
Opioid Recovery Centers would serve as models for comprehensive treatment and recovery and would utilize the full range of Food and Drug Administration approved medications and evidence-based treatments, have strong linkages with the community, generate meaningful outcomes data, and
dramatically improve the opportunities for individuals to establish and maintain long-term recovery. Either directly or through coordination with other entities, Centers must provide services including withdrawal management, counseling, recovery housing, community-based and peer recovery support services, job training and placement assistance, pharmacy and toxicology services, and a secure and confidential electronic health information system.
HR 5353 Eliminating Opioid Related Infectious Diseases Act of 2018 Introduced March 20, 2018 by Leonard Lance (R-NJ) Authorizes the Centers for Disease Control (CDC) to undertake an injection drug-use associated infection elimination initiative and work with states to improve education,
surveillance, and treatment of infections associated with injection drug use.
HR 3331 To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology Introduced July 20, 2017 by Lynn Jenkins (R-KY) authorizes the Center for Medicare and Medicaid
Innovation to test a program offering incentive payments to behavioral health providers that adopt and use certified electronic health record technology. The U.S. government introduced the Meaningful Use program as part of the 2009 Health Information Technology for Economic and Clinical Health (HITECH) Act, to encourage health care providers to show "meaningful use" of a certified Electronic Health Record (EHR). In doing so, eligible providers who do so receive incentive payments, but behavioral health providers were not included in the definition of eligible providers. Individual physicians and other eligible health care professionals can each receive up to $44,000 through the Medicare Meaningful Use program or up to $63,750 through the Medicaid Meaningful Use program, depending upon when they begin attesting to the program's requirements.
HR 3528 Every Prescription Conveyed Securely Act Introduced July 28, 2017 by Katherine Clark (D-MA) To amend title XVIII of the Social Security Act to require e-prescribing for coverage under Part D of the Medicare program of prescription drugs that are controlled substances.
HR 4841 Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018 Introduced January 18, 2018 by David Schweikert (R-AZ) To amend title XVIII of the Social Security Act to provide for electronic prior authorization under Medicare Part D for covered Part D drugs, and for other purposes.
HR 5675 To amend title XVIII of the Social Security Act to require prescription drug plan sponsors under the Medicare program to establish drug management programs for at-risk beneficiaries Introduced May 3, 2018 by Gus Bilirakis (R-FL) This bill requires Medicare prescription drug plan (PDP) sponsors, for plan years beginning on or after January 1, 2021, to establish drug management programs for at-risk beneficiaries. Current law authorizes, but does not require, PDP sponsors to establish such programs.
HR 5686 Medicare Clear Health Options in Care for Enrollees Act of 2018 Introduced May 7, 2018 by Erik Paulsen (R-MN) To amend title XVIII of the Social Security Act to require prescription drug plans under Medicare part D to include information on the adverse effects of opioid overutilization and of coverage of nonpharmacological therapies and nonopioid medications or devices used to treat pain.
HR 5582 Abuse Deterrent Access Act of 2018 Introduced April 23, 2018 by Buddy Carter (R-GA) Requires the Secretary of the Department of Health and Human Services (HHS) to report to Congress on existing barriers to access to abuse-deterrent opioid formulations by Medicare Part C and D
beneficiaries.
HR 5684 Protecting Seniors From Opioid Abuse Act Introduced May 7, 2018 by Mike Kelly (R-PA) To amend title XVIII of the Social Security Act to expand eligibility for medication therapy management programs established under Part D of the Medicare program to include certain individuals who are at risk for prescription drug abuse.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits
HR 173 Middle Class Health BEnefit Tax Repeal Act Introduced January 3, 2-17 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 5963 Introduced May 24, 2018 by Kristi Noem (R-SD) To delay the reimposition of the annual fee on health insurance providers until after 2020.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2018
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 24, 2018.
Original Filing: 300959067.xml
Lobbying Issues
Affordable Care Act (ACA) Regulations; Postal Reform; Health Care Reform; Reinsurance; CSRs (Cost Sharing Reductions); Implementation; Drug Pricing; Individual Market Reform; Market Stabilization; AHPs (Association Health Plans); Waivers; Small Group Market Reform; STLD (Short Term Limited Duration); HIT (Health Insurance Tax); 2018 Direct Consumer Benefit; Grace Periods; Third Party Payment of Premiums; SEPs (Special Enrollment Periods); Catastrophic Coverage Beyond Age 30; Tax Credits; Graham-Cassidy Legislation; Collins-Nelson Legislation; Alexander-Murray Legislation.
H.R. 4163 -- 115th Congress (2017-2018)
S.1354 -- 115th Congress (2017-2018)
Individual Health Insurance Marketplace Improvement Act
Sponsor: Sen. Carper, Thomas R. [D-DE] (Introduced 06/14/2017)
S.2221 -- 115th Congress (2017-2018)
Postal Service Reform Act of 2017
Sponsor: Rep. Chaffetz, Jason [R-UT-3] (Introduced 01/31/2017)
H.R. 246 -- 115th Congress (2017-2018) To Repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. Sponsor: Rep. Noem, Kristi L. [R-SD-At Large] (Introduced 01/04/2017)
H.R.2575 -- 115th Congress (2017-2018) BENES Act of 2017 Sponsr: Rep. Ruiz, Raul [D-CA-36] (Introduced 05/19/2017)
1.H.R.2430 -- 115th Congress (2017-2018) FDA Reauthorization Act of 2017
1.H.R.314 -- 115th Congress (2017-2018) Health Care Choice Act of 2017
1.H.R. 2051 -- 115th Congress (2017-2018) FAST Generics Act of 2017
H.R.4666 -- 115th Congress (2017-2018) Premium Relief Act of 2017 Exchange Act
1.H.R.1101 -- 115th Congress (2017-2018) Small Business Health Fairness Act of 2017
1.H.R.2400 -- 115th Congress (2017-2018) To amend Title 5, United States Code, to allow individuals who are not Federal employees to enroll in the Federal Employees Health Benefits Program, and for other purposes.
1.H.R.708 -- 115th Congress (2017-2018) State Age Rating Flexibility Act of 2017
1.H.R.2889 -- 115th Congress (2017-2018) Closing Loopholes for Orphan Drugs Act
1.H.R.2212 -- 115th Congress (2017-2018) CREATES Act of 2017
1.H.R.1409 -- 115th Congress (2017-2018) Cancer Drug Parity Act of 2017
1.H.R.749 -- 115th Congress (2017-2018) Lower Drug Costs through Competition Act
1.H.R.4666 -- 115th Congress (2017-2018) Premium Relief Act of 2017
1.H.R.3976 -- 115th Congress (2017-2018) Access to Marketplace Insurance Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Drug Pricing; Opioid use/substance abuse disorders
Agencies Lobbied
U.S. Senate
Lobbying Issues
CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Rate Notice and Call Letter; Postal Reform; Medigap.
H.R.1148 -- 115th Congress (2017-2018)
FAST Act of 2017 Sponsor: Rep. Griffith, H. Morgan [R-VA-9] (Introduced 02/16/2017)
H.R.4998 -- 115th Congress (2017-2018)
H.R.4005 -- 115th Congress (2017-2018)
H.R.3331 -- 115th Congress (2017-2018)
To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology.
Sponsor: Rep. Jenkins, Lynn [R-KS-2] (Introduced 07/20/2017)
H.R.3528 -- 115th Congress (2017-2018)
Every Prescription Conveyed Securely Act
Sponsor: Rep. Clark, Katherine M. [D-MA-5] (Introduced 07/28/2017)
H.R.4841 -- 115th Congress (2017-2018)
Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018
Sponsor: Rep Schweikert, David [R-AZ-6] (Introduced 01/18/2018)
H.R.3192 -- 115th Congress (2017-2018)
CHIP Mental Health Parity Act
Sponsor: Rep. Kennedy, Joseph P., III [D-MA-4] (Introduced 07/12/2017)
H.R. 756 -- 115th Congress (2017-2018) Postal Service Reform Act of 2017 Sponsor: Rep. Chaffetz, Jason [R-UT-3] (Introduced 01/31/2017)
H.R.2575 -- 115th Congress (2017-2018) BENES Act of 2017 Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 05/19/2017)
H.R.3780 -- 115th Congress (2017-2018) Air Ambulance Quality and Accountability Act Sponsor: Rep. Hudson, Richard [R-NC-8] (Introduced 09/14/2017)
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT Tax); Tax Credits; Tax Reform
H.R.1 -- Public Law No: 115-97
An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
Sponsor: Rep. Brady, Kevin [R-TX-8] (Introduced 11/02/2017)
H.R.173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2-17 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2017
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 22, 2018.
Original Filing: 300935968.xml
Lobbying Issues
Drug pricing; Opioid use/substance abuse disorders
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Healthcare Act (ACA) Regulations; Postal Reform; Health Care Reform; Reinsurance; Cost Sharing Reductions (CSRs); Implementation; Drug Pricing; Individual Market Reform; Market Stabilization; AHPs (Association Health Plans); Waivers; Small Group Market Reform; STLD (Short Term Limited Duration); HIT (Health Insurance Tax); Grace Periods; Third Party Payment of Premiums; SEPs (Special Enrollment Periods); Catastrophic Coverage beyond age 30; Tax Credits; Graham-Cassidy Legislation; Collins-Nelson Legislation; Alexander-Murray Legislation
HR 173 -- 115th Congress (2017-2018) Middle Class Health Benefits Tax Repeal Act of 2017. Sponsor: Rep. Kelly, Mike [R-PA-3] (Introduced 01/03/2017).
HR 246 -- 115th Congress (2017-2018) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act. Sponsor: Rep. Noem, Kristi L. [R-SD-At Large] (Introduced 01/04/2017)
HR 2575 -- 115th Congress (2017-2018) BENES Act of 2017 Sponsor: Rep. Ruiz, Raul [D-CA-36] (Introduced 05/19/2017).
1. HR 2430 -- 115th Congress (2017-2018) FDA Reauthorization Act of 2017.
1. HR 314 -- 115th Congress (2017-2018) Health Care Choice Act of 2017.
1. HR 2051 -- 115th Congress (2017-2018) FAST Generics Act of 2017.
1. HR 1101 -- 115th Congress (2017-2018) Small Business Health Fairness Act of 2017.
1. HR 2400 -- 115th Congress (2017-2018)To amend title 5, United States Code, to allow individuals who are not Federal employees to enroll in the Federal Employees Health Benefits Program, and for other purposes.
1. HR 180 -- 115th Congress (2017-2018) To amend title XIX of the Social Security Act to eliminate the requirement for 3 months of retroactive coverage under the Medicaid program.
1. HR 4666 -- 115th Congress (2017-2018) Premium Relief Act of 2017.
1. HR 3976 -- 115th Congress (2017-2018) Access to Marketplace Insurance Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Rate Notice and Call Letter; Postal Reform; Medigap
H.R. 756 -- 115th Congress (2017-2018) Postal Service Reform Act of 2017. Sponsor: Rep. Chaffetz, Jason [R-UT-3] (Introduced 01/31/2017).
H.R. 3780 -- 115th Congress (2017-2018) Air Ambulance Quality and Accountability Act. Sponsor: Rep Hudson, Richard [R-NC-8] (Introduced 09/14/2017).
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Tax Credits; Tax Reform
HR 1 -- An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018.
HR 173 Middle Class Health Benefit Tax Repeal Act. Introduced January 3, 2-17 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 31, 2017.
Original Filing: 300918391.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Healthcare Act (ACA) Regulations; Postal Reform; American Health Care Act (AHCA); Health Care Reform; Health Savings Accounts (HSAs); Reinsurance; Cost Sharing Reductions (CSRs); Implementation; Third Party Payment of Premiums (TPP); Repeal and Replace; Drug Pricing; Risk Ratios; Individual Market Reform; Market Stability; Marketplace Certainty Act; Mental Health Parity; 2019 Notice of Benefit and Payment Parameters; Grace Periods; SEPs; Senate Health Reform Bill (AHCA); Preventive Services; Association of Health Plans; Selling Across State Lines
HR 246 -- 115th Congress (2017-2018) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
HR 1628 -- 115th Congress (2017-2018) American Health Care Act of 2017.
S 1354 -- 115th Congress (2017-2018) Individual Health Insurance Marketplace Improvement Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Rate Notice and Call Letter; Medigap
H.R. 3780 -- 115th Congress (2017-2018) Air Ambulance Quality and Accountability Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Cadillac Tax; Tax Credits
HR 173 Middle Class Health Benefit Tax Repeal Act
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
No issues in Budget/Appropriations this period.
2nd Quarter, 2017
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 20, 2017.
Original Filing: 300895245.xml
Lobbying Issues
Opioid Abuse; Drug Pricing;
HR 2026 Pharmaceutical Information Exchange Act Introduced April 6, 2017 by Brett Guthrie (R-VA) To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers.
HR 2051 FAST Generics Act Introduced April 6, 2017 by David McKinley (R-WV) To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible product developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Healthcare Act (ACA) Regulations; Postal Reform; American Health Care Act (AHCA); Health Care Reform; Health Savings Accounts (HSAs); Reinsurance; Cost Sharing Reductions (CSRs); Implementation; Special Needs Plans (SNP); Third Party Payment of Premiums (TPP); Repeal and Replace; Drug Pricing; Risk Ratios; Individual Market Reform; Market Stability; Marketplace Certainty Act; Mental Health Parity; 2017 Notice of Benefit and Payment Parameters; Grace Periods; SEPs; Senate Health Reform Bill
HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 314 Introduced January 5, 2017 by Marsha Blackburn (R-TN) To repeal title I of the Patient Protection and Affordable Care Act and to amend the Public Health Service Act to provide for cooperative governing of individual health insurance coverage offered in interstate commerce.
HR 756 Postal Service Reform Act of 2017 Introduced January 31, 2017 by Jason Chaffetz (R-UT) To restore the financial solvency and improve the governance of the United States Postal Service in order to ensure the efficient and affordable nationwide delivery of mail, and for other purposes.
HR 1101 Small Business Health Fairness Act of 2017 Introduced February 16, 2017 by Sam Johnson (R-TX) To amend Title I of the Employee Retirement Income Security Act of 1974 to improve access and choice for enterpreneurs with small businesses with respect to medical care for their employees.
HR 1628 American Health Care Act Introduced March 20, 2017 by Diane Black (R-TN) The American Health Care Act of 2017 (AHCA), also known as the Better Care Reconciliation Act of 2017 (BCRA), is the leading proposal to "repeal and replace" the Affordable Care Act (aka Obamacare, but we'll abbreviate it ACA) and "defund" Planned Parenthood.
HR 1703 Introduced March 23, 2017 by Morgan Griffith (R-VA) To amend the Federal Food, Drug, and Cosmetic Act with respect to determining the intended use of drugs and devices.
HR 2026 Pharmaceutical Information Exchange Act Introduced April 6, 2017 by Brett Guthrie (R-VA) To improve patient access to emerging medication therapies by clarifying the scope of permitted health care economic and scientific information communications between biopharmaceutical manufacturers and population health decision makers.
HR 2051 FAST Generics Act Introduced April 6, 2017 by David McKinley (R-WV) To amend the Federal Food, Drug, and Cosmetic Act to ensure that eligible produce developers have competitive access to approved drugs and licensed biological products, so as to enable eligible product developers to develop and test new products, and for other purposes.
HR 2400 Introduced May 8, 2017 by Darrell Issa (R-CA) To amend title 5, United States Code, to allow individuals who are not Federal employees to enroll in the Federal Employees Health Benefits Program, and for other purposes.
HR 2430 Introduced May 10, 2017 by Greg Walden (R-OR) To amend the Federal Food,Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
S 1354 Individual Health Insurance Marketplace Improvement Act introduced June 14, 2017 by Thomas Carper (D-DE) A bill to establish an Individual Market Reinsurance fund to provide funding for State individual market stabilization reinsurance programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Rate Notice and Call Letter; Postal Reform; Medigap
HR 756 Postal Service Reform Act of 2017 Introduced January 31, 2017 by Jason Chaffetz (R-UT) To restore the financial solvency and improve the governance of the United States Postal Service in order to ensure the efficient and affordable nationwide delivery of mail, and for other purposes.
HR 2575 Introduced May 19, 2017 by Raul Ruiz (R-CA) To amend Title XVIII of the Social Security Act to establish a system to educate individuals approaching Medicare eligibility, to simplify and modernize the eligibility enrollment process, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT Tax); Cadillac Tax; Tax Credits
HR 173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2017 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
No issues in Budget/Appropriations this period.
1st Quarter, 2017
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 20, 2017.
Original Filing: 300876021.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Healthcare Act (ACA) Regulations; American Health Care Act (AHCA); Health Care Reform; Implementation; Cost Sharing Reduction (CSR); Reinsurance; Health Savings Accounts (HSAs); Repeal and Replace; Grace Periods; SEPs; Marketplace Stability; Individual Marketplace Reform; Antitrust; Medical Malpractice Reform; Association Health Plans
HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 633 Patient Fairness and Relief Act of 2017 Introduced January 24, 2017 by Gregg Harper (R-MS) To authorize health insurance issuers to continue to offer for sale health insurance coverage offered in the individual market before the enactment of the Patient Protection and Affordable Care Act in satisfaction of the minimum essential health insurance coverage requirement, and for other purposes.
HR 708 State Age Rating Flexibility Act of 2017 Introduced by Larry Bucshon (R-IN) This bill amends the Public Health Service Act to increase the permissible variation based on age for health insurance premiums for coverage offered in the individual or small group market from a factor of three to a factor of five, or to a factor determined by the state. This applies to plan years starting on or after January 1, 2018.
HR 710 Health Coverage State Flexibility Act of 2017 Introduced January 17, 2017 by Bill Flores (R-TX) This bill amends the Patient Protection and Affordable Care Act to revise the grace period that health insurers must provide to recipients of premium subsidies before discontinuing health coverage for nonpayment of premiums. The grace period is shortened from 3 months to 30 days unless state law includes an applicable grace period.
HR 706 Plan Verification and Fairness Act of 2017 Introduced January 27, 2017 by Marsha Blackburn (R-TN) This bill amends the Patient Protection and Affordable Care Act to require health insurance exchanges to verify an individual's eligibility for a special enrollment period before coverage is made effective. Individuals seeking coverage through an exchange during a special enrollment period must submit to the exchange the documents necessary to verify their eligibility for the special enrollment period.
HR 661 Employee Fairness and Relief Act of 2017 Introduced January 24, 2017 by Brett Guthrie (R-KY) To authorize health insurance issuers to offer for sale previously available health insurance coverage in the small group market in satisfaction of the minimum essential health insurance coverage requirement, and for other purposes.
HR 749 Lower Drug Costs Through Competition Act Introduced January 30, 2017 by Kurt Schrader (D-OR) To increase competition in the pharmaceutical industry.
HR 1101 Small Business Health Fairness Act of 2017 Introduced February 16, 2017 by Sam Johnson (R-TX) To amend Title I of the Employee Retirement Income Security Act of 1974 to improve access and choice for entrepreneurs with small businesses with respect to medical care for their employees.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medigap; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Exchanges
HR 1290 Improving Access to Mental Health Act Introduced March 1, 2017 by Barbara Lee (D-CA) To amend Title XVIII of the Social Security Act to improve access to mental health services under the Medicare program.
HR 1435 Exchange Inclusion for a Healthy America Act Introduced March 8, 2017 by Luis Gutierrez (D-IL) To amend the Patient Protection and Affordable Care Act to remove citizenship and immigration barriers to access the Exchanges under such Act.
HR 1621 Protecting Seniors from Health Care Fraud Act of 2017 Introduced March 17, 2017 by Raul Ruiz (D-CA) This bill amends Title XVIII (Medicare) of the Social Security Act to direct the Department of Health and Human Services (HHS) to report annually to Congress and the public on: (1) the ten most prevalent health care fraud schemes targeted to seniors, (2) steps being taken to combat such schemes, and (3) policy suggestions to improve protections for seniors. HHS may omit certain information from an annual report if public disclosure would compromise an ongoing investigation or educate criminals rather than seniors. HHS shall disseminate reports to Medicare beneficiaries as specified by the bill.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax (HIT Tax); Cadillac Tax
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
ACA Reinsurance; Cost-sharing Reduction Payments under ACA
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2017.
Original Filing: 300851913.xml
Lobbying Issues
Opioid Abuse; Opiod Education; Prescription Drugs
HR 953 Introduced February 12, 2015 by James Sensenbrenner, JR. (R-WI) Comprehensive Addiction and Recovery Act of 2015 Overdoses from heroin,prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related deaths in America, according to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. Heroin overdoses have more than tripled in the last five years, an issue receiving outsize attention nationally but especially during the presidential campaign season as New Hampshire has been one of the hardest-hit states.
New legislation aims to tackle this epidemic. The Comprehensive Addiction and Recovery Act, S. 524 and H.R. 953, was introduced by Sen. Sheldon Whitehouse (D-RI) and Rep. Jim Sensenbrenner (R-WI5) and will receive a hearing on Thursday from the Senate Judiciary Committee.
HR 2805 Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement-Act of 2015 Introduced June 17, 2015 by Susan Brooks (R-IN). This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA), to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication.
HR 4499 Introduced February 9, 2016 by Alex Mooney (R-VA) Promoting Responsible Opioid Prescribing Act of 2016. To amend Title XVIII of the Social Security Act to remove consideration of certain pain-related issues from calculations under the Medicare hospital value-based purchasing program, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act Issues: ACA Regulations; Postal Reform; HCR Implementation; Health Savings Accounts (HSAs); Re-insurance; Notice of Benefit and Payment Parameters (NBPP); Health Care Bill; Market Stability; Year-end Priorities; Cost-sharing Reductions (CSR); "Better Way"; Repeal/Replace Modeling; ACA Reform; Risk Corridors; Chronic Care; Comprehensive Care and Recovery Act (CARA); Mental Health Reform; Premium Education; Third Party Payment of Premiums; Association Health Plans; SEPs; Grace Periods; Age Bands.
HR 928 Introduced February 1, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 3742 Access to Marketplace Insurance Act Introduced October 9, 2015 by Kevin Cramer (R-ND) To amend the Patient Protection and Affordable Care Act to allow for certain third party payments.
HR 5410 Health Coverage State Flexibility Act of 2016 Introduced June 8, 2016 by Bill Flores (R-TX) to amend the Patient Protection and Affordable Care Act to better align the grace period required for non-payment of premiums before discontinuing coverage under qualified health plans with such grace periods provided for under State law.
HR 5447 Small Business Health Care Relief Act of 2016 Introduced June 21, 2016 by Charles Boustany, Jr. (R-LA) To provide an exception from certain group health plan requirements for qualified small employer health reimbursement arrangements.
HR 5589 Plan Verification and Fairness Act of 2016 Introduced June 28, 2016 by Marsha Blackburn (R-TN) To amend title I of the Patient Protection and Affordable Care Act to require verification for eligibility for enrollment during special enrollment periods in PPACA insurance plans, and for other purposes.
HR 5904 Tax Payers Before Insurers Act Introduced July 14, 2016 by Mark Walker (R-NC) To require the Secretary of Health and Human Services to deposit certain funds into the general fund of the Treasury in accordance with provisions of Federal law with regard to the Patient Protection and Affordable Care Act's Transitional Reinsurance Program.
HR 5921 State Age Rating Flexibility Act Introduced July 21, 2016 by Larry Bucshon (R-IN) To amend title XXVII of the Public Health Service Act to change the permissible age variation in health insurance premium rates.
S. 524 Comprehensive Addiction and Recovery Act of 2016 Introduced February 12, 2015 by Sheldon Whitehouse (D-RI) Overdoses from heroin, prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related death in America, according to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. Heroin overdoses have more than tripled iin the last five years, an issue receiving outsize attention nationally but especially during the presidential campaign season as New Hampshire has been one of the hardest-hit states.
S. 1697 Small Business Healthcare Relief Act Introduced June 25, 2015 by Charles Grassley (R-IA) A bill to provide an exception from certain group health plan requirements to allow small businesses to use pre-tax dollars to assist employees in the purchase of policies in the individual health insurance market, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medigap; Exchanges; Network Breadth Advisory Council; Rate Notice and Call Letter.
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT Tax); HIT Tax Delay; Cadillac Tax
HR928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
S 183 Jobs and Premium Protection Act Introduced January 16, 2015 by John Barrasso (R-WY) A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Risk Corridors; ACA Reinsurance; Cost-sharing Reduction Payments under ACA
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 21, 2016.
Original Filing: 300840451.xml
Lobbying Issues
Opioid Abuse; Opiod Education; Prescription Drugs; Pharmaceutical Innovation.
HR 953 Introduced February 12, 2015 by James Sensenbrenner, JR. (R-WI) Comprehensive Addiction and Recovery Act of 2015 Overdoses from heroin,prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related deaths in America, according to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. Heroin overdoses have more than tripled in the last five years, an issue receiving outsize attention nationally but especially during the presidential campaign season as New Hampshire has been one of the hardest-hit states.
New legislation aims to tackle this epidemic. The Comprehensive Addiction and Recovery Act, S. 524 and H.R. 953, was introduced by Sen. Sheldon Whitehouse (D-RI) and Rep. Jim Sensenbrenner (R-WI5) and will receive a hearing on Thursday from the Senate Judiciary Committee.
HR 2805 Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement-Act of 2015 Introduced June 17, 2015 by Susan Brooks (R-IN). This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA), to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication.
HR 4499 Introduced February 9, 2016 by Alex Mooney (R-VA) Promoting Responsible Opioid Prescribing Act of 2016. To amend Title XVIII of the Social Security Act to remove consideration of certain pain-related issues from calculations under the Medicare hospital value-based purchasing program, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act Issues: Chronic Care Innovations; Payment Reform; 2017 Notice of Benefit and Payment Parameters (NBPP); ACA Regulations; Co-ops; Implementation; Market Stability; Department of Labor Conflict of Interest Rule; Grace Periods; Special Enrollment Periods (SEPs); Reinsurance; Risk Corridors; Risk Mitigation; Risk Programs; Premiums; Health Reimbursement Arrangements (HRAs) Legislation; Individual Market Reform; Third-Party Payments; Exchanges;; Age Bands.
Other Health Care Issues -- Mental Health Reform; End Stage Renal Disease (ESRD); Zika Virus; Postal Reform; Health Savings Accounts
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 2646 Helping Families in Mental Health Crisis Act of 2015 Introduced May 4, 2015 by Tim Murphy (R-PA) To make available needed psychiatric, psychological, and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
HR 3742 Access to Marketplace Insurance Act Introduced October 9, 2015 by Kevin Cramer (R-ND) To amend the Patient Protection and Affordable Care Act to allow for certain third party payments.
HR 5410 Health Coverage State Flexibility Act of 2016 Introduced June 8, 2016 by Bill Flores (R-TX) to amend the Patient Protection and Affordable Care Act to better align the grace period required for non-payment of premiums before discontinuing coverage under qualified health plans with such grace periods provided for under State law.
HR 5447 Small Business Health Care Relief Act of 2016 Introduced June 21, 2016 by Charles Boustany, Jr. (R-LA) To provide an exception from certain group health plan requirements for qualified small employer health reimbursement arrangements.
HR 5506 Introduced June 15, 2016 by Todd Young (R-IN) To amend title XVIII of the Social Security Act to establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes.
HR 5547 Health Care Price Transparency Promotion Act of 2016 Introduced by Michael Burgess (R-IN) To amend Title XIX of the Social Security Act to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs.
HR 5589 Plan Verification and Fairness Act of 2016 Introduced June 28, 2016 by Marsha Blackburn (R-TN) To amend Title I of the Patient Protection and Affordable Care Act to require verification for eligibility for enrollment during special enrollment periods in PPACA insurance plans, and for other purposes.
H.R. 5904 Tax Payers Before Insurers Act Introduced July 14, 2016 by Mark Walker (R-NC) To require the Secretary of Health and Human Services to deposit certain funds into the general fund of the Treasury in accordance with provisions of Federal law with regard to the Patient Protection and Affordable Care Act's Transitional Reinsurance Program.
H.R. 5921 State Age Rating Flexibility Act Introduced July 21, 2016 by Larry Bucshon (R-IN) To amend Title XXVII of the Public Health Service Act to change the permissible age variation in health insurance premium rates.
S. 524 Comprehensive Addiction and Recovery Act of 2016 Introduced February 12, 2015 by Sheldon Whitehouse (D-RI) Overdoses from heroin, prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related deaths in America, according to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. Heroin overdoses have more than tripled in the last five years, an issue receiving outsize attention nationally but especially during the presidential campaign season as New Hampshire has been one of the hardest-hit states.
S. 1697 Small Business Healthcare Relief Act Introduced June 25, 2015 by Charles Grassley (R-IA) A bill to provide an exception from certain group health plan requirements to allow small businesses to use pre-tax dollars to assist employees in the purchase of policies in the individual health insurance market, and for other purposes.
S. 1945 Mental Health Reform Act of 2015 Introduced August 5, 2015 by Bill Cassidy (R-LA) A bill to make available needed psychiatric, psychological, and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
S. 2713 Introduced March 17, 2016 by Lamar Alexander (R-TN) Advancing Precision Medicine Act of 2016 A bill to provide for the implementation of a Precision Medicine Initiative.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medigap; CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Chronic Care Reform; Exchanges; Site-Neutral Payments; Quality Improvement Strategy for QHPs; Rate Notice and Call Letter; QHP Quality Rating System (QRS); MHP; FAQ 8 and 9; Form 5500; Schedule J.
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT Tax); Cadillac Tax
HR928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
S 183 Jobs and Premium Protection Act Introduced January 16, 2015 by John Barrasso (R-WY) A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Risk Corridors; Risk Corridor Funding; ACA Reinsurance
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 20, 2016.
Original Filing: 300818772.xml
Lobbying Issues
Opioid Abuse; Opiod Education; Prescription Drugs; Pharmaceutical Innovation.
HR 953 Introduced February 12, 2015 by James Sensenbrenner, JR. (R-WI) Comprehensive Addiction and Recovery Act of 2015 Overdoses from heroin,prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related deaths in America, accordiing to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. Heroin overdoses have more than tripled in the last five years, an issue receiving outsize attention nationally but especially during the presidential campaign season as New Hampshire has been one of the hardest-hit states.
New legislation aims to tackle this epidemic. The Comprehensive Addiction and Recovery Act, S. 524 and H.R. 953, was introduced by Sen. Sheldon Whitehouse (D-RI) and Rep. Jim Sensenbrenner (R-WI5) and will receive a hearing on Thursday from the Senate Judiciary Committee.
HR 2805 Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement-Act of 2015 Introduced June 17, 2015 by Susan Brooks (R-IN). This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration (DEA), to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication.
HR 4499 Introduced February 9, 2016 by Alex Mooney (R-VA) Promoting Responsible Opioid Prescribing Act of 2016. To amend Title XVIII of the Social Security Act to remove consideration of certain pain-related issues from calculations under the Medicare hospital value-based purchasing program, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act Issues: Chronic Care Innovations; Payment Reform; Small Group Expansion; Payment Reform; 2017 Notice of Benefit and Payment Parameters (NBPP); ACA Regulations; Co-ops; Implementation; Cyber Security; Open Enrollment; Market Stability; Department of Labor Conflict of Interest Rule; Grace Periods; Special Enrollment Periods (SEPs); Department of Labor Fiduciary Rule; Reinsurance; Taskforce; Premiums; Health Reimbursement Arrangements (HRAs) Legislation; Individual Market Reform.
Other Health Care Issues -- Mental Health Parity; Opioid Education; End Stage Renal Disease (ESRD); Zika Virus; Air Ambulances.
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 2646 Helping Families in Mental Health Crisis Act of 2015 Introduced May 4, 2015 by Tim Murphy (R-PA) To make available needed psychiatric, psychological, and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
HR 3742 Access to Marketplace Insurance Act Introduced October 9, 2015 by Kevin Cramer (R-ND) To amend the Patient Protection and Affordable Care Act to allow for certain third party payments.
HR 5410 Health Coverage State Flexibility Act of 2016 Introduced June 8, 2016 by Bill Flores (R-TX) to amend the Patient Protection and Affordable Care Act to better align the grace period required for non-payment of premiums before discontinuing coverage under qualified health plans with such grace periods provided for under State law.
HR 5447 Small Business Health Care Relief Act of 2016 Introduced June 21, 2016 by Charles Boustany, Jr. (R-LA) To provide an exception from certain group health plan requirements for qualified small employer health reimbursement arrangements.
HR 5506 Introduced June 15, 2016 by Todd Young (R-IN) To amend title XVIII of the Social Security Act to establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes.
HR 5547 Health Care Price Transparency Promotion Act of 2016 Introduced by Michael Burgess (R-IN) To amend Title XIX of the Social Security Act to provide for increased price transparency of hospital information and to provide for additional research on consumer information on charges and out-of-pocket costs.
HR 5589 Plan Verification and Fairness Act of 2016 Introduced June 28, 2016 by Marsha Blackburn (R-TN) To amend Title I of the Patient Protection and Affordable Care Act to require verification for eligibility for enrollment during special enrollment periods in PPACA insurance plans, and for other purposes.
S. 524 Comprehensive Addiction and Recovery Act of 2016 Introduced February 12, 2015 by Sheldon Whitehouse (D-RI) Overdoses from heroin, prescription drugs, and opioid pain relievers last year surpassed car accidents as the leading cause of injury-related deaths in America, according to the Centers for Disease Control. Deaths have reached their highest levels of the 21st century in 2014, the most recent year for which data is available, according to the National Institute on Drug Abuse. Heroin overdoses have more than tripled in the last five years, an issue receiving outsize attention nationally but especially during the presidential campaign season as New Hampshire has been one of the hardest-hit states.
S. 1697 Small Business Healthcare Relief Act Introduced June 25, 2015 by Charles Grassley (R-IA) A bill to provide an exception from certain group health plan requirements to allow small businesses to use pre-tax dollars to assist employees in the purchase of policies in the individual health insurance market, and for other purposes.
S. 1945 Mental Health Reform Act of 2015 Introduced August 5, 2015 by Bill Cassidy (R-LA) A bill to make available needed psychiatric, psychological, and supportive services for individuals with mental illness and families in mental health crisis, and for other purposes.
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) To amend Title I of the Patient Protection and Affordable Care Act and Title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medigap; CHIP Reform; Medicare Access & CHIP Reauthorization Act of 2015 (MACRA); Chronic Care Reform; Exchanges; ICD-10; Site-Neutral Payments; Medicare Fraud; Quality Improvement Strategy for QHPs; Rate Notice and Call Letter; Medical Billing; Transparency Tools; QHP Quality Rating System (QRS)
HR 3716 Introduced October 8, 2015 by Larry Bucshon (R-IN) To amend Title XIX of the Social Security Act to require States to provide to the Secretary of Health and Human Services certain information with respect to provider terminations, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT Tax); Cadillac Tax
HR928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Risk Corridors; Risk Corridor Funding; Federal Employee Health Benefits Plan (FEHBP)Regional PPO Language; ACA Reinsurance; Postal Reform
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 22, 2016.
Original Filing: 300804114.xml
Lobbying Issues
Opioid Abuse; Prescription Drugs; Pharmaceutical Innovation.
HR 953 Introduced February 12, 2015 by James Sensenbrenner, JR. (R-WI) To authorize the Attorney General to award grants to address the national epidemics of prescription opioid abuse and heroin use.
HR 2805 Introduced July 17, 2015 by Susan Brooks (R-IN) To address prescription opioid abuse and heroin use.
HR 4499 Introduced February 9, 2016 by Alex Mooney (R-VA) Promoting Responsible Opioid Prescribing Act of 2016. To amend Title XVIII of the Social Security Act to remove consideration of certain pain-related issues from calculations under the Medicare hospital value-based purchasing program, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act Issues: Chronic Care Innovations; Small Group Expansion; Payment Reform; 2017 Notice of Benefit and Payment Parameters (NBPP); ACA Regulations; Co-ops; Implementation; Cyber Security; Open Enrollment; Market Stability; Department of Labor Conflict of Interest Rule; Grace Periods; Special Enrollment Periods (SEPs).
Other Health Care Issues -- Mental Health Parity; Opioid Education.
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) To amend Title I of the Patient Protection and Affordable Care Act and Title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medigap; CHIP Reform; Chronic Care Reform; Exchanges; ICD-10; Nondiscrimination Delivery System Reform; Enrollee Experience Survey-Technical Expert Panel; Quality Improvement Strategy for QHPs; Rate Notice and Call Letter; Transparency Tools; All Payer Claims Databases
HR 3716 Introduced October 8, 2015 by Larry Bucshon (R-IN) To amend Title XIX of the Social Security Act to require States to provide to the Secretary of Health and Human Services certain information with respect to provider terminations, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT Tax); Cadillac Tax
HR928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Risk Corridors; Federal Employee Health Benefits Plan (FEHBP)Regional PPO Language
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2016.
Original Filing: 300775647.xml
Lobbying Issues
Pharmaceutical Innovation; Patent Reform; Cures
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act Issues: Chronic Care Innovations; Small Group Expansion; Payment Reform; CBPP; 2017 Notice of Benefit and Payment Parameters; ACA Regulations; Co-ops; Innovations for Healthier Americans Act; Implementation; Cyber Security; Open Enrollment; Market Stability; Agency Health Research Quality (AHRQ)
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (R-MI)This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH)through FY2018. The NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and high-risk, high-reward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) To amend Title I of the Patient Protection and Affordable Care Act and Title XXVII of the Public Health Service Act to revise the definition of small employer.
S. 1099 Introduced April 27, 2015 by Tim Scott (R-SC) A bill to amend the Patient Protection and Affordable Care Act to provide States with flexibility in determining the size of employers in the small group market.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues: Medigap; CHIP Reform; Chronic Care Reform; Exchanges; ICD-10;Nondiscrimination Delivery System Reform; Provider Lookup Tool; Quality Improvement Strategy for QHPs
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (R-MI) This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and high-risk, high-reward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
833; Health Insurance Tax (HIT Tax); Cadillac Tax IRA 2015-68 Notice
HR928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Risk Corridors; Reinsurance; Regional PPO Language
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2015.
Original Filing: 300764356.xml
Lobbying Issues
Pharmaceutical Innovation; HELP Cures Bill Information
Lobbying Issues
Affordable Care Act Issues: Small group expansion; Risk Corridors; Delivery system reform; Consumer experience; back end issues; Implementation issues; Regulations; Premiums; Exchanges; Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity; Reinsurance; Health care quality issues; Patient reform; Payment reform; Medical Loss Ratios;
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM;
S 123 Introduced January 8, 2015 by Marco Rubio (R-FL) Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a program of risk corridors for calendar years 2014, 2015, and 2016.
S. 1099 Introduced April 27, 2015 by Tim Scott (R-SC) A bill to amend the Patient Protection and Affordable Care Act to provide States with flexibility in determining the size of employers in the small group market.
HR 221 Introduced January 8, 2015 by Andy Harris (R-MD)Taxpayer bailout of health insurers.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) To amend title I of the Patient Protection and Affordable Care Act and Title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues:Medigap
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (R-MI) This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax; IRC Section 833(b) tax provisions; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Cadillac tax
HR928 Introduced February 12, 2015 by Charles Boustany (R-LA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
S183 Introduced January 16, 2015 by John Barrasso (R-WY) Jobs and Premium Protection Act This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Risk Corridors; Reinsurance
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
Blue Cross and Blue Shield of Kansas, Inc. amended a lobbying report for in-house lobbying in Q22015 on July 22, 2015
Original Filing: 300747365.xml
Lobbying Issues
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (R-MI) This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. THe NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and high-risk, high-reward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act Issues: Small group expansion; Risk Corridors; Delivery system reform; Consumer experience; back end issues; Implementation issues; Regulations; Premiums; Exchanges; Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity; Reinsurance; Health care quality issues; Patient reform; Payment reform; Medical Loss Ratios;
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM;
S 123 Introduced January 8, 2015 by Marco Rubio (R-FL) Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a program of risk corridors for calendar years 2014, 2015, and 2016.
S. 1099 Introduced April 27, 2015 by Tim Scott (R-SC) A bill to amend the Patient Protection and Affordable Care Act to provide States with flexibility in determining the size of employers in the small group market.
HR 221 Introduced January 8, 2015 by Andy Harris (R-MD)Taxpayer bailout of health insurers.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) To amend title I of the Patient Protection and Affordable Care Act and Title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas; Medicare A & B; Delivery System Reforms; Benefit Restructuring; Medigap; Community Health Management; Medicare fraud; Cybersecurity; ICD-10; Medicare Prescription Drug Integrity; Provider Directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (R-MI) This bill amends the Public Health Services Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and high-risk, high-reward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments and preventive measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax; Cadillac tax; Tax extenders; Tax reform.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (R-WY) Jobs and Premium Protection Act This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
ACA Risk Corridors Federal Health Employee Benefit Program (FEHBP) offerings; Government contribution to FEHBP premiums; Reinsurance; Regional PPO Language
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 20, 2015.
Original Filing: 300746027.xml
Lobbying Issues
21st Century Cures
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (R-MI) This bill amends the Public Health Service Act to reauthorize the National Institutes of Health (NIH) through FY2018. THe NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and high-risk, high-reward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments, and preventive measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Affordable Care Act Issues: Small group expansion; Risk Corridors; Delivery system reform; Consumer experience; back end issues; Implementation issues; Regulations; Premiums; Exchanges; Supreme Court decision implications
Other Major Health Care Related Issues: Cybersecurity; Reinsurance; Health care quality issues; Patient reform; Payment reform; Medical Loss Ratios;
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM;
S 123 Introduced January 8, 2015 by Marco Rubio (R-FL) Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a program of risk corridors for calendar years 2014, 2015, and 2016.
S. 1099 Introduced April 27, 2015 by Tim Scott (R-SC) A bill to amend the Patient Protection and Affordable Care Act to provide States with flexibility in determining the size of employers in the small group market.
HR 221 Introduced January 8, 2015 by Andy Harris (R-MD)Taxpayer bailout of health insurers.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) To amend title I of the Patient Protection and Affordable Care Act and Title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare/Medicaid Issues: Chronic care improvement ideas; Medicare A & B; Delivery System Reforms; Benefit Restructuring; Medigap; Community Health Management; Medicare fraud; Cybersecurity; ICD-10; Medicare Prescription Drug Integrity; Provider Directories
HR 6 21st Century Cures Act Introduced May 19, 2015 by Fred Upton (R-MI) This bill amends the Public Health Services Act to reauthorize the National Institutes of Health (NIH) through FY2018. The NIH Innovation Fund is established to fund a strategic plan, early stage investigators, and high-risk, high-reward research. The NIH may require scientific data to be shared if the research is fully funded by the NIH. The NIH and the Food and Drug Administration (FDA) must implement a system that allows further research on clinical trial data. The Centers for Disease Control and Prevention must expand surveillance of neurological diseases. The Council for 21st Century Cures is established to accelerate the discovery, development, and delivery of innovative cures, treatments and preventive measures. The Department of Health and Human Services must monitor the use of antibacterial and antifungal drugs and resistance to these drugs.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax; Cadillac tax; Tax extenders; Tax reform.
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (R-WY) Jobs and Premium Protection Act This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
ACA Risk Corridors Federal Health Employee Benefit Program (FEHBP) offerings; Government contribution to FEHBP premiums; Reinsurance; Regional PPO Language
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 24, 2015.
Original Filing: 300728767.xml
Lobbying Issues
Affordable Care Act Issues: Risk Corridors; back end issues; implementation issues; Premiums; Exchanges; CHIP
Cybersecurity; Small Group Expansion; Reinsurance; Health care quality issues; Selling insurance across state lines
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
S123 Introduced January 8, 2015 by Marco Rubio (R-FL) Obamacare Taxpayer Bailout Prevention Act Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services to establish and administer a program of risk corridors for calendar years 2014, 2015, and 2016 under which it qualified.
HR 221 Introduced January 8, 2015 by Andy Harris (R-MD) Taxpayer bailout of health insurers.
HR 1624 Introduced March 25, 2015 by Brett Guthrie (R-KY) to amend Title I of the Patient Protection and Affordable Care Act and Title XXVII of the Public Health Service Act to revise the definition of small employer.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring; Medigap first-dollar coverage; Summary of Benefits Rule
Cybersecurity
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Health Insurance Tax;
HR 928 Introduced February 12, 2015 by Charles Boustany (R-LA) To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
S 183 Introduced January 16, 2015 by John Barrasso (R-WY) Jobs and Premium Protection Act. This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
ACA Risk Corridors, Federal Health Employee Benefit Program (FEHBP) offerings; Government contribution to FEHBP premiums; SHOP Employer Choice; Reinsurance; Regional PPO Language
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2015.
Original Filing: 300701099.xml
Lobbying Issues
Affordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees:
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM.
FEHBP Modernization Act circulation draft President's budget, regional PPOs, government contributions
HR 2667 Introduced by Griffin (R-AR) on July 11, 2013
Authority for Mandate Delay Act
HR 2668 Introduced by Young (R-IN) on July 17, 2013
Fairness for Families Act
Bailouts for Insurance Companies, S. 1726, H.R. 3541, 3812, 3851, 4406
HR 2328 Introduced in House June 12, 2013 Rep. Rogers, Mike J. (R-MI)
Access to Professional Health Insurance Advisors Act of 2013 - Amends the Public Health Service Act to exclude remuneration paid for licensed independent insurance producers from administrative cost calculations for purposes of calculating the medical-loss ratio of a health insurance plan.
HR 3541 introduced by Tim Griffin November 19, 2013 Obamacare Taxpayer Bailout Prevention Act - Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services (HHS) to establish and administer a program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified health plan offered in the individual or small group market is required to participate in a payment adjustment system based on the ration of the allowable costs of the plan to the plan's aggregate premiums.
Other general Affordable Care Act topics related to multiple parts of legislation: ACA Implementation and back-end issues; Multi-State Plan Program Implementation; Risk Corridors and Risk Mitigation; Reinsurance; Small Business Health Options Program (SHOP) implementation; Third-Party payment of premiums; Electronic Health Records (EHRs); Health IT Roadmap; Contraception Rule; Expatriate Legislation.
S. 1486 Introduced August 1, 2013 by Sen. Carper,Thomas R. (D-DE)
Postal Reform Act of 2013 - Amends provisions of federal law relating to the funding of the U.S.Postal Service (USPS) retirement and health care systems, operations, revenue, and governance. Section 104 Substitute Amendment.
HR 3362 Introduced October 29, 2013 by Rep. Terry, Lee (R-NE)
Exchange Information Disclosure Act - Amends the Patient Protection and Affordable Care Act to expand reporting requirements related to health care exchanges. Requires the Secretary of Health and Human Services (HHS) to publish reports weekly through March 31, 2015, on: (1) consumer interactions with healthcare.gov or subsequent sites and any efforts undertaken to remedy problems that impact taxpayers and consumers, (2) calls to the federal customer service call center, including the number of calls received by the call center, problems identified by users, and referrals of those calls; (3) all navigators and certified application counselors that have been trained and certified by health care exchanges; and (4) all agents and brokers who have been trained and certified by the federal health care exchange.
HR 762 Introduced in House February 15, 2013 by Rep. Blackburn, Marsha (R-TN)
Health Care Choice Act of 2013 - Prohibits the Secretary of Health and Human Services (HHS) from implementing, administering, or enforcing specified regulations insofar as they would replace International Classification of Diseases (ICD-9) with ICD-10 as a standard for code sets for appropriate data elements for financial and administrative transactions involving the electronic exchange of health information.
HR 3985 Introduced February 3, 2014 by Lynn Westmoreland (R-GA) Prohibits health insurance issuers and third-party administrators, or any period after December 31, 2014, from being requirement to make payments under the Patient Protection and Affordable Care Act (PPACA) for a transitional reinsurance program for the individual health insurance market in each state. Allows payments to issuers, as limited by this Act, only to the extent of available funds. Limits to 2014 the applicability of the program of risk corridors, under which a qualified health plan offered in the individual or small group market shall participate in a payment adjustment system based on the ratio of the allowable costs of the plan to the plan's aggregate premiums.
HR 4496 Introduced April 28, 2014 by Cory Gardner (R-CO) Covering People With Pre-Existing Conditions Act of 2014 - Requires each state to mitigate the health costs of high risk individuals in the state through a state reinsurance program or a state high risk pool.
HR 4777 Introduced May 30, 2014 by Michael Burgess (R-TX) To amend the Internal Revenue Code of 1986 to modify rules relating to health savings accounts.
HR 3522 Introduced November 18, 2013 by Bill Cassidy (R-LA) To authorize health insurance issuers to continue to offer for sale current group health insurance coverage in satisfaction of the minimum essential health insurance coverage requirement, and for other purposes.
HR 5214 Introduced July 28, 2014 by Pete Olsen (R-TX) To require the Secretary of Health and Human Services to provide for recommendations for the development and use of clinical data registries for the improvement of patient care.
HR 3750 Introduced December 12, 2013 by Donna Matsui (D-CA) Telehealth Modernization Act of 2013 - Calls for states to authorize health care professionals to deliver health care to individuals through telehealth and to consider adopting conditions under which such a professional should have access to the individual's medical history.
HR 4633 Introduced May 9, 2014 by H. Griffith (R-VA) Insurance Rate Transparency Act - Amends the Public Health Service Act to require that specific health insurance premium increase information submitted to the Secretary of Health and Human Services (HHS) be disclosed to Congress no later than 30 days after receipt of the information.
HR 5453 Introduced September 11, 2014 by Bruce Braley (D-IA) To authorize health insurance issuers to continue to offer for sale current group health insurance coverage in satisfaction of the minimum essential health insurance coverage requirement, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring; Medigap first-dollar coverage; Quality Initiatives/SGR Reform, HIPAA Code Adoption Process, Medicare Advantage Risk Delay
Part D Cuts, HR 2810 Introduced by Burgess (R-TX) on July 31, 2013
HR 3392 Introduced October 13, 2013 by Gus Bilirakis (R-FL) To amend title XVIII of the Social Security Act to provide for a PDP safety program to prevent fraud and abuse in the dispensing of controlled substances under Part D of the Medicare program, and for other purposes.
Multi-State Plan Programs, Medicare Patient Access and Quality Improvement Act of 2013, Medicare Prescription Drug Integrity. Medicare fraud; Provider terminations in Medicare Advantage; CHIP (Children's Health Insurance Program) reauthorization
HR 4160 Introduced March 6, 2014 by Renee Ellmers (R-NC) Keep the Promise to Seniors Act of 2014 - Prohibits the Secretary of Health and Human Services (HHS) from taking any action (through promulgation of a final or interim final regulation, issuance of regulatory or program guidance, use of federal payment audit procedures, or other enforcement or administrative action, policy, or practice) to implement any provision of the proposed regulation (relating to policy and technical changes to the MedicareAdvantage and part D programs under Medicare) published in the Federal Register on January 10, 2014, insofar as that regulation relates to part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA), including its application to MedicareAdvantage-Prescription Drug (MA-PD) plans under part C (Medicare+Choice Program).
HR 4577 Introduced May 6, 2014 by H. Griffith (R-VA) Ensuring Seniors Access to Local Pharmacies Act of 2014 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII(Medicare) of the Social Security Act with respect to a prescription drug plan that has, in its network of pharmacies, one or more pharmacies located in a health professional shortage area, in a medically underserved area, or among a medically underserved population, and that provides a reduction in coinsurance or copayments for covered part D drugs dispensed through them. Declares that such a plan shall extend to any pharmacy located in that area or among that population the option to be an in-network pharmacy with respect to such plan under terms and conditions comparable to those the plan has agreed upon with other in-network pharmacies located in the area or among that population.
HR 2960 Introduced August 1, 2013 by Frank Pallone (D-NJ) Medicare Prescription Drug Integrity Act of 2013 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require a prescription drug plan (PDP) sponsor to have in place procedures designed to prevent fraud and abuse in PDPs.
HR 5083 Introduced July 11, 2014 by Renee Ellmers (R-NC) Medicare DMEPOS Audit Improvement and Reform (AIR) Act of 2014 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to establish a Medicare Administrative Contractor Payment Outreach and Education Program for DMEPOS (durable medical equipment, prosthetics, orthotics, and supplies) suppliers.
HR 5460 Introduced September 11, 2014 by Greg Walden (R-OR) to amend title XVIII of the Social Security Act to increase access to ambulance services under the Medicare program and to reform payments for such services under such program as introduced.
HR 5547 Introduced September 18, 2014 by Matthew Cartwright (D-PA) to ensure that Medicaid beneficiaries have the opportunity to receive care in a home and community-based setting.
HR 5558 Introduced September 18, 2014 by Diane Black (R-TN) to amend Title XVIII of the Social Security Act to improve the Medicare accountable care organization (ACO) program, and for other purposes.
HR 4494 Introduced June 26, 2014 by Dave Camp (R-MI) Improving Medicare Post-Acute Care Transformation Act of 2014 or the IMPACT Act of 2014 - Amends title XVIII (Medicare) of the Social Security Act to direct the Secretary of Health and Human Services (HHS) to provide for standardized post-acute care assessment data for quality, payment, and discharge planning, and for other purposes.
HR 2925 Introduced August 1, 2013 by Kevin Brady (R-TX) Strengthening Medicare Anti-Fraud Measures Act of 2013 - Amends title XI of the Social Security Act to authorize the Secretary of HHS to exclude from participation in any federal care program entities affiliated with a sanctioned entity, as well as any officer or managing employee of an affiliated entity (currently, only individuals with an ownership or control interest in a sanctioned entity), if the affiliated entity was so affiliated at the time of any of the conduct forming the basis for the conviction or exclusion of the sanctioned entity.
HR 645 - /ABLE Act Introduced February 13, 2013 by Ander Crenshaw (R-FL) Achieving a Better Life Experience Act of 2014 or the ABLE Act of 2014 - Title I: Qualified ABLE Programs - (Sec. 101) States as the purposes of this title to: (1) encourage and assist individuals and families in saving private funds for the purpose of supporting individuals with disabilities to maintain health, independence, and quality of life; and (2) provide secure funding for disability-related expenses of beneficiaries with disabilities that will supplement, but not supplant, benefits provided through private insurance, title XVI (Supplemental Security Income) and title XIX (Medicaid) of the Social SEcurity Act, the beneficiary's employment, and other sources.
HR 4994 Introduced June 26, 2014 by Dave Camp (R-MI) Title XVIII amendments of Social Security Act.
Other Medicare/Medicaid Issues:
Delivery reform and network design; Qualified Health Plan Survey; CHIP Reauthorization; Medicare co-pay limits
Agencies Lobbied
U.S. Senate
Lobbying Issues
IRC section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Health Insurance Ttax; Health Insurance Excise Tax, S. 603/HR 763, HR 3367,; Tax Extenders; HR 83 and HJ Res 124 Consolidated appropriations.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
ACA Risk Corridors, Omnibus, Federal Health Employee Benefit Program offerings; SHOP Employer Choice; Reinsurance; Regional PPO Language; HR 83 and HJ Res 124 Consolidated appropriations
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2014.
Original Filing: 300685375.xml
Lobbying Issues
Affordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers;
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
FEHBP Modernization Act circulation draft President's budget, regional PPOs, government contributions
HR 2667 Introduced by Griffin (R-AR) on July 11, 2013
Authority for Mandate Delay Act
HR 2668 Introduced by Young (R-IN) on July 17, 2013
Fairness for Families Act
Bailouts for Insurance Companies, S. 1726, H.R. 3541, 3812, 3851, 4406
HR 3541 introduced by Tim Griffin November 19, 2013 Obamacare Taxpayer Bailout Prevention Act - Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services (HHS) to establish and administer a program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified health plan offered in the individual or small group market is required to participate in a payment adjustment system based on the ratio of the allowable costs of the plan to the plan's aggregate premiums.
Other general Affordable Care Act topics related to multiple parts of legislation: ACA Implementation and back-end issues; Multi-State Plan Program Implementation; Risk Corridors and Risk Mitigation; Reinsurance; Small Business Health Options Program (SHOP) implementation; Third-party payment of premiums; Electronic Health Records (EHRs); Health IT Roadmap; Contraception Rule; Expatriate Legislation.
S. 1486 Introduced August 1, 2013 by Sen. Carper, Thomas R. (D-DE)
Postal Reform Act of 2013 - Amends provisions of federal law relating nto the funding of the U.S. Postal Service (USPS) retirement and health care systems, operations, revenue, and governance. Section 104 Substitute Amendment.
HR 3362 Introduced October 29, 2013 by Rep. Terry, Lee (R-NE)
Exchange Information Disclosure Act - Amends the Patient Protection and Affordable Care Act to expand reporting requirements related to health care exchanges. Requires the Secretary of Health and Human Services (HHS) to publish reports weekly through March 31, 2015, on: (1) consumer interactions with healthcare.gov or subsequent sites and any efforts undertaken to remedy problems that impact taxpayers and consumers, (2) calls to the federal customer service call center, including the number of calls received by the call center, problems identified by users, and referrals of those calls; (3) all navigators and certified application counselors that have been trained and certified by health care exchanges; and (4) all agents and brokers who have been trained and certified by the federal health care exchange.
HR 762 Introduced in House February 15, 2013 by Rep. Blackburn, Marsha (R-TN)
Health Care Choice Act of 2013 - Repeals the health insurance and health coverage expansion requirements of the Patient Protection and Affordable Care Act and related requirements of the Health Care and Education Reconciliation Act of 2010. Restores provisions of law amended or repealed by such provisions.
HR 4496 Introduced April 28, 2014 by Cory Gardner (R-CO) Covering People With Pre-Existing Conditions Act of 2014 - Requires each state to mitigate the health costs of high risk individuals in the state through a state reinsurance program or a state high risk pool.
HR 3522 Introduced November 18, 2013 by Bill Cassidy (R-LA) To authorize health insurance issuers to continue to offer for sale current group health insurance coverage in satisfaction of the minimum essential health insurance coverage requirement, and for other purposes.
HR 3750 Introduced December 12, 2013 by Donna Matsui (D-CA) Telehealth Modernization Act of 2013 - Calls for states to authorize health care professionals to deliver health care to individuals through telehealth and to consider adopting conditions under which such a professional should: have access to the individual's medical history.
HR 5453 Introduced September 11, 2014 by Bruce Braley (D-IA) To authorize health insurance issuers to continue to offer for sale current group health insurance coverage in satisfaction of the minimum essential health insurance coverage requirement, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring; Medigap first-dollar coverage; Quality Initiatives/SGR Reform, HIPAA Code Adoption Process, Part D Cuts, HR 2810 Introduced by Burgess (R-TX) on July 31, 2013
HR 3392 Introduced October 13, 2013 by Gus Bilirakis (R-FL) To amend Title XVIII of the Social Security Act to provide fo a PDP safety program to prevent fraud and abuse in the dispensing of controlled substances under Part D of the Medicare program, and for other purposes.
HR 4577 Introduced May 6, 2014 by H. Griffith (R-VA) Ensuring Seniors Access to Local Pharmacies Act of 2014 - Amends Part D (Voluntary Prescription Drug Benefit Program) of Title XVIII (Medicare) of the Social Security Act with respect to a prescription drug plan that has, in its network of pharmacies, one or more pharmacies located in a health professional shortage area, in a medically underserved area, or among a medically underserved population, and that provides a reduction in coinsurance or copayments for covered Part D drugs dispensed through them. Declares that such a plan shall extend to any pharmacy located in that area or among that population the option to be an in-network pharmacy with respect to such plan under terms and conditions comparable to those the plan has agreed upon with other in-network pharmacies located in the area or among that population.
HR 2960 Introduced August 1, 2013 by Frank Pallone (D-NJ) Medicare Prescription Drug Integrity Act of 2013 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to require a prescription drug plan (PDP) sponsor to have in place procedures designed to prevent fraud and abuse in PDPs.
HR 5547 Introduced September 18, 2014 by Matthew Cartwright (D-PA) To ensure that Medicaid beneficiaries have the opportunity to receive care in a home and community-based setting.
HR 5558 Introduced September 18, 2014 by Diane Black (R-TN) To amend title XVIII of the Social Security Act to improve the Medicare accountable care organization (ACO) program, and for other purposes.
Agencies Lobbied
U.S. Senate
Lobbying Issues
IRC section 833(b) tax provisions; Health Insurance Tax: Health Insurance Excise Tax,
S. 603/HR 763, HR 3367
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2014
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 21, 2014.
Original Filing: 300667037.xml
Lobbying Issues
No pharmacy lobbying activity reported during the 2nd quarter.
Lobbying Issues
Affordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on premiums; Healthcare Deliver System Reforms.
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database.
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees.
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Federal Employee Health BEnefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
FEHBP Modernization Act circulation draft President's budget, regional PPOs, government contributions
HR 2667 Introduced by Griffin (R-AR) on July 11, 2013
Authority for Mandate Delay Act
HR 2668 Introduced by Young (R-IN) on July 17, 2013
Fairness for Families Act
Bailouts for Insurance Companies, S. 1726, H.R. 3541, 3812, 3851, 4406
HR 2328 Introduced in House June 12, 2013 Rep. Rogers, Mike J. (R-MI)
Access to Professional Health Insurance Advisors Act of 2013 - Amends the Public Health Service Act to exclude remuneration paid for licensed independent insurance producers from administrative cost calculations for purposes of calculating the medical-loss ratio of a health insurance plan.
HR 3541 introduced by Tim Griffin November 19, 2013 Obamacare Taxpayer Bailout Prevention Act - Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services (HHS) to establish and administer a program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified health plan offered in the individual or small group market is required to participate in a payment adjustment system based on the ratio of the allowable costs of the plan to the plan's aggregate premiums.
Other general Affordable Care Act topics related to multiple parts of legislation: ACA Implementation and back-end issues; Multi-State Plan Program Implementation; Risk Corridors and Risk Mitigation; Reinsurance; Small Business Health Options Program (SHOP) implementation; Third-party payment of premiums; Electronic Health Records (EHRs); Health IT Roadmap; Contraception Rule
S. 1486 Introduced August 1, 2013 by Sen. Carper, Thomas R. (D-DE)
Postal Reform Act of 2013 - Amends provisions of federal law relating to the funding of the U.S. Postal Service (USPS) retirement and health care systems, operations, revenue and governance. Section 104 Substitute Amendment.
HR 3362 Introduced October 29, 2013 by Rep. Terry, Lee (R-NE)
Exchange Information Disclosure Act - Amends the Patient Protection and Affordable Care Act to expand reporting requirements related to health care exchanges. Requires the Secretary of Health an Human Services (HHS) to publish reports weekly through March 31, 2015, on: (1) consumer interactions with healthcare.gov or subsequent sites and any efforts undertaken to remedy problems that impact taxpayers and consumers, (2) calls to the federal customer service call center, including the number of calls received by the call center, problems identified by users, and referrals of those calls; (3) all navigators and certified application counselors that have been trained and certified b health care exchanges; and (4) all agents and brokers who have been trained and certified by the federal health care exchange.
HR 762 Introduced in House February 15, 2013 by Rep. Blackburn, Marsha (R-TN)
Health Care Choice Act of 2013 - Repeals the health insurance and health coverage expansion requirements of the Patient Protection and Affordable Care Act and related requirements of the Health Care and Education Reconciliation Act of 2010. Restores provisions of law amended or repealed by such provisions.
HR 1701 Introduced April 24, 2013 by Ted Poe (T-TX)
Cutting Costly Codes Act of 2013 - Prohibits the Secretary of Health and Human Services (HHS) from implementing, administering, or enforcing specified regulations insofar as they would replace International Classification of Diseases (ICD-9) with ICD-10 as a standard for code sets for appropriate data elements for financial and administrative transactions involving the elecronic exchange of health information.
HR 3985 Introduced February 3, 2014 by Lynn Westmoreland (R-GA)
Prohibits health insurance issuers and third-party administrators, for any period after December 31, 2014, from being required to make payments under the Patient PRotection and Affordable Care Act (PPACA) for a transitional reinsurance program for the individual health insurance market in each state. Allows payments to issuers, as limited by this Act, only to the extent of available funds. Limits to 2014 the applicability of the program of risk corridors, under which a qualified health plan offered in the individual or small group market shall participate in a payment adjustment system based on the ratio of the allowable costs of the plan to the plan's aggregate premiums.
HR 4496 Introduced April 28, 2014 by Cory Gardner (R-CO) Covering People With Pre-Existing Conditions Act of 2014 - Requires each state to mitigate th health costs of high risk individuals in the state through a state reinsurance program or a state high risk pool.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring; Medigap first-dollar coverage; Quality Initiatives/SGR Reform, HIPAA Code Adoption Process, HR 2810 Introduced by Burgess (R-TX) on July 31, 2013
HR 3392 Introduced October 13, 2013 by Gus Bilirakis (R-FL)
To amend Title XVIII of the Social Security Act to provide for a PDP safety program to prevent fraud and abuse in the dispensing of controlled substances under Part D of the Medicare program, and for other purposes.
Multi-Sate Plan Programs, Medicare Patient Access and Quality Improvement Act of 2013, Medicare Prescription Drug Integrity, Medicare Fraud; Provider Terminations in Medicare Advantage
Agencies Lobbied
U.S. Senate
Lobbying Issues
IRC Section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Health Insurance Tax: Health Insurance Excise Tax, S. 603/HR 763, HR 3367.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2014
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 17, 2014.
Original Filing: 300640246.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareAffordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees
HealthCare Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Guaranteed Issue; Community Rating; Age Rating; Health Savings Accounts
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
FEHBP Modernization Act circulation draft President's budget, regional PPOs, government contributions
HR 2667 Introduced by Griffin (R-AR) on July 11, 2013
Authority for Mandate Delay Act
HR 2668 Introduced by Young (R-IN) on July 17, 2013
Fairness for Families Act
Bailouts for Insurance Companies, S. 1726, H.R. 3541, 3812, 3851
HR 2328 Introduced in House June 12, 2013 Rep. Rogers, Mike J. (R-MI)
Access to Professional Health Insurance Advisors Act of 2013 - Amends the Public Health Service Act to exclude remuneration paid for licensed independent insurance producers from administrative cost calculations for purposes of calculating the medical-loss ration of a health insurance plan.
HR 3541 introduced by Tim Griffin November 19, 2013 Obamacare Taxpayer Bailout Prevention Act - Repeals the provision of the Patient Protection and Affordable Care Act that directs the Secretary of Health and Human Services (HHS) to establish and administer a program of risk corridors for calendar years 2014, 2015, and 2016 under which a qualified health plan offered in the individual or small group market is required to participate in a payment adjustment system based on the ratio of the allowable costs of the plan to the plan's aggregate premiums.
Other general Affordable Care Act topics related to multiple parts of legislation: Delay of Individual Mandate; ACA Implementation; Multi-State Plan Program Implementation; Risk Corridors and Risk Mitigation; Reinsurance; Small Business Health Options Program (SHOP) implementation
S. 1486 Introduced August 1, 2013 by Sen. Carper, Thomas R. (D-DE)
Postal Reform Act of 2013 - Amends provisions of federal law relating to the funding of the U.S. Postal Service (USPS) retirement and health care systems, operations, revenue, and governance. Section 104 Substitute Amendment.HR 3362 Introduced October 29, 2013 by Rep. Terry, Lee (R-NE)
Exchange Information Disclosure Act - Amends the Patient Protection and Affordable Care Act to expand reporting requirements related to health care exchanges. Requires the Secretary of Health and Human Services (HHS) to publish reports weekly through March 31, 2015, on: (1) consumer interactions with healthcare.gov or subsequent sites and any efforts undertaken to remedy problems that impact taxpayers and consumers, (2) calls to the federal customer service call center, including the number of calls received by the call center, problems identified by users, and referrals of those calls; (3) all navigators and certified application counselors that have been trained and certified health care exchanges; and (4) all agents and brokers who have been trained and certified by the federal health care exchange.
HR 762 Introduced in House February 15, 2013 by Rep. Blackburn, Marsha (R-TN)
Health Care Choice Act of 2013 - Repeals the health insurance and health coverage expansion requirements of the Patient Protection and Affordable Care Act and related requirements of the Health Care and Education Reconciliation Act of 2010. Restores provisions of law amended or repealed by such provisions.
HR 1701 Introduced April 24, 2013 by Ted Poe (R-TX)
Cutting Costly Codes Act of 2013 - Prohibits the Secretary of Health and Human Services (HHS) from implementing, administering, or enforcing specified regulations insofar as they would replace International Classification of Diseases (ICD)-9 with ICD-10 as a standard for code sets for appropriate data elements for financial and administrative transactions involving the electronic exchange of health information.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring; Medigap first-dollar coverage; Quality Initiatives/SGR Reform, HIPAA Code Adoption Process, Part D Cuts, HR 2810 Introduced by Burgess (R-TX) on July 31, 2013 Multi-State Plan Programs, Medicare Patient Access and Quality Improvement Act of 2013, Medicare Prescription Drug Integrity.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC Section 833(b) tax provisions; Health Spending Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction; Health Insurance Tax: Health Insurance Excise Tax, S. 603/HR 763, HR 3367
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2013
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 22, 2014.
Original Filing: 300628015.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: Reasonable regulatory implementation timeline for compliance with PL 111-148
Affordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers
Health Care Quality; Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/ Medical Home; Evidence Based Care; Wellness; Chronic Care Management
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Guaranteed Issue; Community Rating; Age Rating; Health Savings Accounts
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
HR 2667 Introduced by Griffin (R-AR) on July 11, 2013
Authority for Mandate Delay Act
HR 2668 Introduced by Young (R-IN) on July 17, 2013
Fairness for Families Act
S. 1488 Introduced in Senate September 9, 2013
Fairness for American Families Act - Amends the Internal Revenue Code, as amended by the Patient Protection and Affordable Care Act (PPACA), to delay until 2015 the requirement that individuals maintain minimal essential health care coverage.
Authority for Mandate Delay Act - Amends PPACA to delay until 2015 enforcement of requirements that large employers offer their full-time employees the opportunity to enroll in minimum essential coverage. Delays the effective date of related reporting requirements for such employers and for providers of minimum essential coverage.
HR 3350 Passed House without amendment November 15, 2013
Keep Your Health Plan Act of 2013 - Permits a health insurance issuer that has in effect health insurance coverage in the individual market as of January 1, 2013, to continue offering such coverage for sale during 2014 outside of a health care exchange established under the Patient Protection and Affordable Care Act. Treats such coverage as a grandfathered health plan for purposes of an individual meeting the requirement to maintain minimum essential health coverage.
S. 1486 Introduced August 1, 2013 by Sen. Carper, Thomas R. (D-DE) Postal Reform Act of 2013 - Amends provisions of federal law relating to the funding of the U.S. Postal Service (USPS) retirement and health care systems, operations, revenue, and governance.
HR 3362 Introduced October 29, 2013 by Rep. Terry, Lee (R-NE)
Exchange Information Disclosure Act - Amends the Patient Protection and Affordable Care Act to expand reporting requirements related to health care exchanges. Requires the Secretary of Health and Human Services (HHS) to publish reports weekly through March 31, 2015, on: (1) consumer interactions with healthcare.gov or subsequent sites and any efforts undertaken to remedy problems that impact taxpayers and consumers, (2) calls to the federal customer service call center, including the number of calls received by the call center, problems identified by users, and referrals of those calls; (3) all navigators and certified application counselors that have been trained and certified by health care exchanges; and (4) all agents and brokers who have been trained and certified by the federal health care exchange.
HR 762 Introduced in House February 15, 2013 by Rep. Blackburn, Marsha (R-TN)
Health Care Choice Act of 2013 - Repeals the health insurance and health coverage expansion requirements of the Patient Protection and Affordable Care Act and related requirements of the Health Care and Education Reconciliation Act of 2010. Restores provisions of law amended or repealed by such provisions.
H.J. Res. 59 making continuing appropriations for fiscal year 2014, and for other purposes; providing for consideration of motions to suspend the rules; providing for proceedings during the period from December 14, 2013, through January 6, 2014.
HR 460 Introduced in House February 4, 2013 Rep. McKinley, David B. (R-WV)
Patients' Access to Treatments Act of 2013 - Amends the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure. Prohibits such a health plan from imposing cost-sharing requirements, including co-payment and co-insurance, application to prescription drugs in a specialty drug tier that exceed the dollar amount of cost-sharing requirements applicable to prescription drugs in a non-preferred brand drug tier. Applies the non-preferred brand drug tier for which beneficiary cost-sharing is lowest, if a formulary used by the health plan contains more than one non-preferred brand drug tier.
Grandfathering and Delay of Individual Mandate
ACA Implementation
Multi-state Plan Program Implementation
Risk Corridors
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring; Medigap first-dollar coverage;
Quality Initiatives/SGR Reform
HR 2810 Introduced by Burgess (R-TX) on July 31, 2013
Medicare Patient Access and Quality Improvement Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Insurance Tax: Health Insurance Excise Tax, HR 763, HR 3367
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2013
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 22, 2013.
Original Filing: 300608154.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: Reasonable regulatory implementation timeline for compliance with PL 111-148
Affordable Private Health Care: Effect of the Health Insurance Tax, defined Essential Health Benefits and Age Rating on premiums; Healthcare Delivery System Reforms
State-based regulation: State oversight of Rates; Properly designed state based health insurance exchanges to improve competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees
Insurance Market Reform: Individual Market Reform; Small Group Market Reform; Guaranteed Issue; Community Rating; Age Rating; Health Savings Accounts
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2013
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 19, 2013.
Original Filing: 300578846.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: reasonable regulatory implementation timeline for compliance with PL 111-148
Affordable Private Health Care: effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on premiums; Healthcare Delivery System Reforms
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database
Medical Loss Ratios: Level Playing Field for MLRs; Consistent reporting requirements for all insurers; MLR Broker Fees:
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical Home; Evidence Based Care; Wellness, Chronic Care Management
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Guaranteed Issue; Community Rating; Age Rating; Health Savings Accounts
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Reforms: Medicare A & B; Delivery System Reforms, Benefit Restructuring; Medigap first-dollar coverage
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2013
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 18, 2013.
Original Filing: 300554016.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: reasonable regulatory implementation timeline for compliance with PL 111-148.
Affordable Private Health Care: effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on premiums; Healthcare Delivery System Reforms.
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve competition and maximize choice; federal exchanges; Multi-State Health Plans; Centralized All-Payer Database.
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Guaranteed Issue; Community Rating; Age Rating.
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPO to be included in the coverage options offered by OPM.
HR 544 Introduced by Gingrey (R-Ga.) on February 6, 2013
Letting Insurance Benefit Everyone Regardless of Their Youth (LIBERTY) Act
HR 763 Introduced by Boustany (R-La.) on February 15, 2013
A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
S 603 Introduced by Barrasso (R-Wyo.) on March 19, 2013
A bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
HR 762 Introduced by Blackburn, M. (R-Tenn.) on February 15, 2013
Health Care Choice Act of 2013
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medigap first-dollar coverage
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Insurance Tax: HR 763 Introduced by Boustany (R-La.) on February 15, 2013 - bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act; S 603 Introduced by Barrasso (R-Wyo.) on March 19, 2013 - bill to repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2012
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 16, 2013.
Original Filing: 300530492.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR-HealthcareAffordable Private Health Care: effect of the Health Insurance Tax, defined Essential Health Benefits, and Age Rating on premiums; Healthcare Delivery System Reforms
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM; HR 2309 "Post Reform Act of 2011" sections pertaining to FEHBP; S1789 "21st Century Postal Service Act of 2012" sections pertaining to Postal Benefits carveout.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medigap first-dollar coverage; S1789 "21st Century Postal Service Act of 2012" sections pertaining to wraparound plan for postal workers with Medicare Part A & B.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Insurance Tax: HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA" and S1880 "Jobs and Premium Protection Act"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2012
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 17, 2012.
Original Filing: 300509577.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: reasonable regulatory implementation timeline for compliance with PL 111-148
Affordable Private Health Care: Health Insurance Tax; Affordable Essential Health Benefits; Inextricable link between Individual Mandate and Insurance Reforms; Healthcare Delivery System Reforms; BCBSA's proposal "Building Tomorrow's Healthcare System: The Pathway to High-Quality, Affordable Care in America"
State-based regulation: State Oversight of Rates; Properly designated state based health insurance exchanges to improve competition and maximize choice; federal exchanges; existing state regulatory functions; Selling Health Insurance across state lines: HR371 'Health Care Choice Act of 2011"; Multi-State Health Plans
Medical Loss Ratios: MLR Broker Fee; State Innovation Waivers; Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller states and Plans; include benefits for individuals as well as populations; MLR Broker Fees: HR1206 "Access to Professional Health Insurance Act of 2011", S 2068 "Access to Independent Health Insurance Advisors Act of 2012"
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care Management; Telemedicine
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification; ICD10 implementation; Data Sharing; Data Aggregation; Centralized All-Payer Database
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Age Rating; Health Status Rating; Individual Mandate; Association Health Plans
Federal Employee Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM; HR 2309 "Postal Reform Act of 2011" sections pertaining to FEHBP; S1789 "21st Century Postal Service Act of 2012" sections pertaining to Postal Benefits carveout; OMB Postal Benefit Carveout
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medigap first-dollar coverage; S1789 "21st Century Postal Service Act of 2012" sections pertaining to wraparound plan for postal workers with Medicare Part A & B; Delivery System Reforms; Physician Payment Alternatives; Fee for Service Payment Reforms; HR 1063 "Strengthening Medicare And Repaying Taxpayers Act of 2011"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Insurance Tax: HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA" and S1880 "Jobs and Premium Protection Act"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2012
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 19, 2012.
Original Filing: 300492663.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: "good faith compliance standard", reasonable regulatory implementation timeline for compliance with PL 111-148.
Affordable Private Health Care: Health Insurance Tax; Affordable Essential Health Benefits; Inextricable link between Individual Mandate and Insurance Reforms; Healthcare Delivery System Reforms; BCBSA's proposal "Building Tomorrow's Healthcare System: The Pathway to High-Quality, Affordable Care in America".
State-based regulation: State Oversight of Rates; Properly designed state based health insurance exchanges to improve competition and maximize choice; federal exchanges; existing state regulatory functions; Selling Health Insurance across state lines: HR371 "Health Care Choice Act of 2011".
Medical Loss Ratios: MLR Broker Fee; State Innovation Waivers; Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller states and Plans; include benefits for individuals as well as populations.
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care Management; Telemedicine.
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification; ICD10 implementation; Data Sharing; Data Aggregation; Centralized All-Payer Database.
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts: HR5858 "Health Savings Accounts Improvement Act of 2012"; Individual Mandate; Association Health Plans.
Federal Employed Health Benefit Program (FEHBP) regarding proposals to allow additional types of carriers including regional PPOs to be included in the coverage options offered by OPM; HR 2309 "Postal reform Act of 2011" sections pertaining to FEHBP; S1789 "21st Century Postal Service Act of 2012" sections pertaining to Postal Benefits carveout; OMB Postal Benefit Carveout; OPM IG's Statement on FEHBP audits.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medigap first-dollar coverage; S1789 "21st Century Postal Service Act of 2012" section pertaining to wraparound plan for postal workers with Medigap Part A & B; Delivery System Reforms; Physician Payment Alternatives.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
MLR Broker Fees: HR1206 "Access to Professional Health Insurance Act of 2011"; Health Insurance Tax: HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA" and S1880 "Jobs and Premium Protection Act".
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2012
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 20, 2012.
Original Filing: 300474253.xml
Lobbying Issues
Deficit; BCBSA's proposal "Building Tomorrow's Healthcare System: the Pathway to High Quality, Affordable Care in America".
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: "good faith compliance standard", reasonable effective dates for compliance with PL 111-148.
Affordable Private Health Care: Insurer Fees; Realistic Essential Health Benefits; Effective Individual Mandate; Healthcare Delivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels; "Most Favored Nation" clauses in provider health contracts; Individual responsibility to obtain and maintain insurance coverage; Health Insurance Excise Tax.
State-based regulation: State Oversight of Premium Increases; Creation of State-based Exchanges; Value of properly designed state health insurance exchanges to improve competition and maximize choices; federal exchanges; federal rate review; existing state regulatory functions.
Medical Loss Ratios: MLR Broker Fee HR1206 "Access to Professional Health Insurance Advisors Act of 2011"; Consistent reporting requirements for all insurers; Transition for smaller states and Plans; include benefits for individuals as well as populations.
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/ Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care Management; Childhood Obesity.
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification; ICD-10 Real Time Claims adjudication; Data Sharing; Data Aggregation; Centralized All-Payer Database.
Insurance Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; MEWAs
BCBSA's proposal "Building Tomorrow's Healthcare System: The Pathway to High-Quality, Affordable Care in America"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medigap First-Dollar Coverage
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC Section 833(b) tax provisions; annual insurer assessments, proposed excise tax on high-value health insurance plans, limitation of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; Health Savings Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction; MLR Broker Fees HR1206 "Access to Professional Health Insurance Act of 2011"; HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2011
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 17, 2012.
Original Filing: 300439462.xml
Lobbying Issues
Deficit; BCBSA's proposal "Building Tomorrow's Healthcare System: the Pathway to High Quality, Affordable Care in America"; Consolidated Appropriations Act of 2012
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: "good faith compliance standard", reasonable effective dates for compliance with PL 111-148.
Affordable Private Health Care: Insurer Fees; Realistic Essential Health Benefits; Effective Individual Mandate; Healthcare Delivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels; "Most Favored Nation" clauses in provider health contracts; Individual responsibility to obtain and maintain insurance coverage; Health Insurance Excise Tax.
State-based regulation: State Oversight of Premium Increases; Creation of State-based Exchanges; Value of properly designed state health insurance exchanges to improve competition and maiximize choices; federal exchanges; federal rate review; existing state regulatory functions; Selling Health Insurance across state lines: HR371 "Health Care Choice Act of 2011"; HR1213 "Repeal mandatory funding provided to States in the PPACA to Establish Benefit Exchanges"; HR5 "HEALTH Act of 2011"
Medical Loss Ratios: MLR Broker Fee HR1206 "Access to Professional Health Insurance Advisors Act of 2011"; State Innovation Waivers; Quality Improvement Definition; Consistent reporting requirements for all insurers; Transition for smaller states and Plans; include benefits for individuals as well as populations
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care Management; Childhood Obesity
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification; ICD10 Real Time Claims adjudication; Data Sharing; Data Aggregation; Centralized All-Payer Database
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; MEWAs
BCBSA's proposal "Building Tomorrow's Healthcare System: The Pathway to High-Quality, Affordable Care in America"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medigap First-Dollar Coverage
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC Section 833(b) tax provisions; annual insurer assessments, proposed excise tax on high-value health insurance plans, limitation of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; Health Savings Accounts; Medical Loss Ratio definition to qualify for 833(b) tax deduction; MLR Broker Fees HR1206 "Access to Professional Health Insurance Act of 2011"; HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2011
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 18, 2011.
Original Filing: 300417730.xml
Lobbying Issues
HR371 "Health Care Choice Act of 2011"; HR1213 "Repeal mandatory funding provided to States in the PPACA to Establish Benefit Exchanges"; Debt Ceiling
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: "good faith compliance standard", reasonable effective dates for compliance with PL 111-148.
Affordable Private Health Care: Insurer Fees; Realistic Essential Health Benefits; Effective Individual Mandate; Healthcare Delivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels; "Most Favored Nation" clauses in provider health contracts; Individual responsibility to obtain and maintain insurance coverage; Health Insurance Excise Tax
State-based regulation: State Oversight of Premium Increases; Creation of State-based Exchanges; Value of properly designed state health insurance exchanges to improve competition and maximize choice; federal exchanges; federal rate review; existing state regulatory functions; Selling Health Insurance across state lines: HR371 "Health Care Choice Act of 2011"; HR1213 "Repeal mandatory funding provided to States in the PPACA to Establish Benefit Exchanges"; HR5 "HEALTH Act of 2011"
State Innovation Waivers; Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller states and Plans; include benefits for individuals as well as populations
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care Management; Childhood Obesity
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification; ICD10 Real time claims adjudication; Data Sharing; Data Aggregation
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; MEWAs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Fraud; Medicaid; Medigap First-Dollar Coverage
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Annual Insurer Assessments, proposed excise tax on high-value health insurance plans; Small Employer Tax Credits; Health Savings Accounts; HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2011
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 20, 2011.
Original Filing: 300401848.xml
Lobbying Issues
HR371 Health Care Choice Act of 2011; HR1213 "Repeal mandatory funding provided to States in the PPACA to Establish BenefitExchanges"; Debt Ceiling; HR1 "Full-Year Continuing Appropriations Act, 2011" Title V and Title VIII
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareAffordable Private Health Care: Insurer Fees; Realistic Essential Health Benefits; Effective Individual Mandate; HealthcareDelivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels; Most Favored Nation clauses inprovider health contracts; Individual responsibility to obtain and maintain insurance coverage; Health Insurance Excise Tax
State-based regulation: State Oversight of Premium Increases; Creation of State-based Exchanges; Value of properly designedstate health insurance exchanges to improve competition and maximize choice; federal exchanges; federal rate review; existingstate regulatory functions; Selling Health Insurance across state lines: HR371 Health Care Choice Act of 2011; HR1213"Repeal mandatory funding provided to States in the PPACA to Establish Benefit Exchanges"; HR5 "HEALTH Act of 2011"
Medical Loss Ratios: MLR Broker Fee HR1206 Access to Professional Health Insurance Advisors Act of 2011; StateInnovation Waivers; Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smallerstates and Plans; include benefits for individuals as well as populations
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered PrimaryCare/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic CareManagement; Childhood Obesity
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; AdministrativeSimplification; ICD10 Real time claims adjudication; Data Sharing; Data Aggregation
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; GuaranteedIssue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate;MEWAs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Fraud; Medicaid; HR1683 and S868 "State Flexibility Act"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Annual insurer assessments, proposed excise tax on high-value health insurance plans, limitationof tax deduction for health insurer's executive compensation; Small Employer Tax Credits; Health Savings Accounts; MLR Broker Fees HR1206 "Access to Professional Health Insurance Act of2011"; HR1370 "To Repeal the annual fee on Health Insurance Providers Enacted by PPACA"
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2011
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 20, 2011.
Original Filing: 300374077.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: "good faith compliance standard", reasonable effective dates for compliance with PL 111-148.
Affordable Private Health Care: Insurer Fees; Realistic Essential Health Benefits; Effective Individual Mandate; Healthcare Delivery Systems Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels; "Most Favored Nations" clauses in provider health contracts; Individual responsibility to obtain and maintain insurance coverage; Health Insurance Excise Tax.
State-based regulation: State Oversight of Premium Increases; Creation of State-based Exchanges; Value of properly designed state health insurance exchanges to improve competition and maximize choice; federal exchanges; federal rate review; existing state regulatory functions; Selling Health Insurance across state lines: HR371 "Health Care Choice Act of 2011".
Medical Loss Ratios: MLR Broker Fee HR1206 "Access to Professional Health Insurance Advisors Act of 2011"; State Innovation Waivers; Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller states and Plans; include benefits for individuals as well as populations.
Health Care Quality: Delivery System Incentives to Promote Better Care; Payment Reforms; Patient-centered Primary Care/Medical Home; Comparative Effectiveness Research; Evidence Based Care; Health Disparities; Wellness; Chronic Care Management; Childhood Obesity.
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification; ICD10 Real time claims adjudication; Data Sharing; Data Aggregation.
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; MEWAs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; annual insurer assessments, proposed excise tax on high-value health insurance plans, limitation of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; Medical Loss Ratio definition to qualify for 833(b) tax deduction; MLR Broker Fees HR1206 "Access to Professional Health Insurance Act of 2011".
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2010
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 21, 2011.
Original Filing: 300355354.xml
Lobbying Issues
Comparative Effectiveness
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: "good faith compliance standard", reasonable effective dates for compliance with PL 111-148
State Oversight of Premium Increases: S 3078 and HR 4757 "Health Insurance Rate Authority Act of 2010"; federal rate review; HR 4700 "Transparency in All Health Care Pricing Act of 2010"; existing state regulatory functions; federal exchanges; state exchanges
Medical Loss Ratios: Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller states and Plans; include benefits for individuals as well as populations
Dependent Health Insurance Coverage: IRS Guidelines on dependent coverage; Pre-existing condition for children; guaranteed issue for children under the age of 19; Child Only Insurance Policies
Recissions and Routine Administrative Functions; Internal Claims and Appeals/External Review; Open enrollment period; adverse selection implications
Affordable Private Health Care: Insurer Fees; Realistic Minimum Benefit Values; Effective Individual Mandate; Healthcare Delivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels
Grandfathering Rules: Interim final rule of June 14th; Flexibility to modify items that are not specifically prohibited
Lifetime and Annual Limits: lifetime and annual dollar limits on "essential health benefits"
Health Care Quality; Patient-centered Primary Care/Medical home; Health Disparities; Wellness; Chronic Care management; Comparative Effectiveness Research; Improved Delivery of Health Care; Evidence Based Care; Healthcare Delivery System Reforms; Childhood Obesity
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification; ICD10 Real time claims adjudication; Data Sharing; Data Aggregation
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; MEWAs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; annual insurer assessments, proposed excise tax on high-value healthinsurance plans, limitation of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; IRS Guidelines on dependent coverage; Medical Loss Ratio definition to quality for 833(b) tax deduction
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2010
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Nov. 1, 2010.
Original Filing: 300332104.xml
Lobbying Issues
Comparative effectiveness, medication safety
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessfuly Insurance Industry Implementation of Health Reforms: "good faith compliance standard", reasonable effective dates for compliance with PL 111-148.
State Oversight of Premium Increases: S 3078 and HR 4757 "Health Insurance Rate Authority Act of 2010"; federal rate review; HR 4700 "Transparency in All Health Care Pricing Act of 2010"; existing state regulatory functions; federal exchanges; state exchanges.
Medical Loss Ratios: Quality improvement definition; Consistent reporting requirements for all insurers; Transition for smaller states and Plans; include benefits for individuals as well as populations.
Dependent Health Insurance Coverage: IRS Guidelines on dependent coverage; Pre-existing condition for children; guaranteed issue for children under the age of 19; Child Only Insurance Policies.
Recissions and Routine Administrative Functions; Internal Claims and Appeals/External Review; Open Enrollment Period; Adverse Selection Implications.
Affordable Private Health Care: Insurer Fees; Realistic Minimum Benefit Values; Effective Individual Mandate; Healthcare Delivery System Reforms; Small Employer Tax Credits; Adequate Insurer Reserve Levels.
Grandfathering Rules: Interim final rule of June 14th; Flexibility to modify items that are not specifically prohibited.
Lifetime and Annual Limits: Lifetime and annual dollar limits on "essential health benefits".
Health Care Quality; Patient-centered Primary Care/Medical Home; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research; Improved Delivery of Health Care; Evidence Based Care; Healthcare Delivery System Reforms; Childhood Obesity.
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification; ICD10 Real time claims adjudication; Data Sharing; Data Aggregation.
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; MEWAs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR 6130 "Strengthening Medicare Anti-Fraud Measures Act of 2010
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Annual Insurer Assessments, proposed excise tax on high-value health insurance plans, limitation of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; IRS Guidelines on dependent coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2010
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 14, 2010.
Original Filing: 300286707.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareSuccessful Insurance Industry Implementation of Health Reforms: "good faith compliance standard", reasonable effective dates for compliance with PL 111-148.
State Oversight of Premium Increases: S 3078 and HR 4757 "Health Insurance Rate Authority Act of 2010"; federal rate review; HR 4700 "Transparency in All Health Care Pricing Act of 2010"; existing state regulatory functions; federal exchanges; state exchanges.
Grandfathering Rules: Interim final rue of June 14th; Flexibility to modify items that are not specifically prohibited.
Medical Loss Ratios: Quality improvement definition; consistent reporting requirements for all insurers; Transition for smaller states and Plans; include benefits for idividuals as well as populations
Dependent Health Insurance Coverage: IRS Guidelines on dependent coverage; BCBS commitment to cover individuals up to age 26 on their parents health insurance; HR5200 "FEHBP Dependent Coverage Extension Act"
Pre-Existing Condition Exclusions: Pre-existing condition for children; guaranteed issue for children under the age of 19
Lifetime and Annual Limits: lifetime and annual dollar limits on "essential health benefits"
Recissions and Patient Protections: Open enrollment nperiod; adverse selection implications
Affordable Private Health Care: Insurer Fees; Realistic Minimum Benefit Values; Effective Individual Mandate; Healthcare Delivery System Reforms; Small Employer Tax Credits
Health Care Quality; Patient-centered Primary Care/Medical Home; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research; Improved Delivery of Health Care; Evidence Based Care; Healthcare Delivery System Reforms
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification; ICD10 Real Time Claims Adjudication
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; MEWAs
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC section 833(b) tax provisions; annual insurer assessments, proposed excise tax on high-value health insurance plans, limitation of tax deduction for health insurer's executive compensation; Small Employer Tax Credits; IRS Guidelines on dependent coverage.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 16, 2010.
Original Filing: 300261231.xml
Lobbying Issues
Comparative Effectiveness Funding in Health Care Reform Legislation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareHealth Care Reform Bill HR3590 "Patient Protection and Affordable Care Act" parts pertaining to health care reform; Health Care Reconciliation Bill HR 4872 "The Health Care & Education Affordability Reconciliation Act of 2010" parts pertaining to health care reform; reasonable effective dates for compliance with insurance reforms; affordable premiums (insurer tax, insufficient cost containment, weak mandate, restricted age discounts, insurer fees); federal health insurance rate authority; national insurance exchange; grandfathering
Health Care Reform; Pathway to Covering America; Employer Based Healthcare System; Uninsured/Expanding Coverage; Healthcare Reform Modeling;
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; Medical Loss Ratios; MEWAs;
Government-run health insurance Plan; Government Plan Trigger, negotiated rates; state opt-out; Co-Ops; Provider Underpayments; Level Playing Field
Affordable Private Health Care; proposed insurer fees; excise taxes on high value Plans; premium caps; 5 to 1 Age Rating Bands; Realistic Minimum Benefit Values; Effective Individual Mandate; Sherlock Report; Healthcare Delivery System Reforms; malpractice reform; Oliver Wyman actuarial analysis "Impact of the Patient Protection and Affordable Care Act on the Costs in the Individual and Small-Employer Health Insurance Markets"; CBO premium impact analysis
New federal regulatory functions; existing state regulatory functions; Federal Exchanges; Federal Connectors; Virtual Connectors; State Insurance Marts (SIMs); Pooling
Health Care Quality; Patient-centered Primary Care/Medical Home; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research; Improved Delivery of Health Care; evidence based care; Healthcare Delivery System Reforms;
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification
Antitrust and Health Insurance Reform; McCarran-Ferguson antitrust exemption repeal legislation: HR 4626 "Health Insurance Industry Fair Competition Act"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Sections of Health Care Reform legislation pertaining to proposed annual insurer assessments, proposed excise tax on high-value health insurance plans, and proposed limitation of tax deduction for health insurer's executive compensation
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2009
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2010.
Original Filing: 300238591.xml
Lobbying Issues
Comparative Effectiveness Funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareHealth Care Reform; Pathway to Covering America; Employer Based Healthcare System; Uninsured/Expanding Coverage; Healthcare Reform Modeling
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate; Medical Loss Ratios
HR 3200 "America's Affordable Health Choices Act of 2009"; Senate Finance Committee Chairman's mark - no bill number "America's Healthy Future Act"; HR 3962 "Affordable Health Care for America Act"; HR 3962 Manager's Amendment; HR 3590 "Patient Protection and Affordable Care Act"; HR 3590 Manager's Amendment
Government-run health insurance Plan; Government Plan Trigger; negotiated rates; state opt-out; Co-Ops; Medicare Payment Rates; Provider Underpayments; Level Playing Field
Affordable Private Health Care; proposed insurer fees; excise taxes on high value Plans; premium caps; 5 to 1 Age Rating Bands; Realistice Minimum Benefit Values; Effective Individual Mandate; Sherlock Report; Healthcare Delivery System Reforms; malpractice reform; Oliver Wyman actuarial analysis "Impact of the Patient Protection and Affordable Care Act on the Costs in the Individual and Small Employer Health Insurance Markets"; CBO premium impact analysis
New federal regulatory functions; existing state regulatory functions; Federal Exchanges; Federal Connectors; Virtual Connectors; State Insurance Marts (SIMs); Pooling
Health Care Quality; Patient-centered Primary Care/Medical Home; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research; Improved Delivery of Health Care; evidence based care; Healthcare Delivery System Reforms;
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification
Antitrust and Health Insurance Reform; McCarran-Ferguson antitrust exemption repeal legislation: S1681 and HR3596 "Health Insurance Industry Antitrust Enforcement Act of 2009
Scope of FEHBP preemption
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicaid
Medigap Guaranteed Issue to Medicare Disabled/ESRD
Medicare Buy-In for those aged 55-64 years of age
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Comparative Effectiveness Research
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC Section 833(b) Tax Provisions
porposed annual insurer assessments, proposed excise tax on high-value health insurance plans, and proposed limitation of tax deduction for health insurer's executive compensation as provided for in healthcare reform proposals
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2009
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2009.
Original Filing: 300216774.xml
Lobbying Issues
Comparative Effectiveness Funding
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area; HCR - HealthcareHealth Care Reform; Pathway to Covering America; Employer Based Healthcare System; Uninsured/Expanding Coverage; Healthcare Reform Modeling;
Insurance Market Reform; Individual Market Reform; Small Group Market Reform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts; Individual Mandate;
HR 3200 "America's Affordable Health Choices Act of 2009"; S1679 "Affordable Health Choices Act"; Senate Finance Committee Chairman's Mark -- no bill number "America's Healthy Future Act"; HR 1321 and S 391 "Healthy Americans Act"
Government-run health insurance Plan; Government Plan Trigger; Co-Ops; Medicare Payment Rates; Provider Underpayments; Level Playing Field
Affordable Private Health Care; proposed insurer fees; excise taxes on high value Plans; 5 to 1 Age Rating Bands; Realistic Minimum Benefit Values; Effective Individual Mandate; Sherlock Report; Healthcare Delivery System Reforms;
Health Care Quality; Patient-Centered Primary Care/Medical Home; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research; Improved Delivery of Health Care; evidence based care; Healthcare Delivery System Reforms;
Pooling, Exchanges, Federal Connectors; Virtual Connectors; State Insurance Marts (SIMs);
Health Information Technology Standards; Health Information Privacy; Electronic Health Records; Administrative Simplification
Antitrust and Health Insurance Reform; HR 3596 "Health Insurance Industry Antitrust Enforcement Act of 2009"
DELETING THE FOLLOWING
HR1321 and S391 "Healthy Americans Act"; HR 1897 and S803 "Healthy Workforce Act of 2009";
S.Res. 156 "A resolution expressing the sense of the Senate that reform of our Nation's health care system should include the establishment of a federally-backed insurance pool".
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicaid
Medigap Guaranteed Issue to Medicare Disabled/ESRD
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC Section 833(b) tax provisions
proposed annual insurer assessments
proposed excise tax on high-value health insurance plans
proposed limitation of tax deduction for health insurer's executive compensation
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2009
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 28, 2009.
Original Filing: 300195988.xml
Lobbying Issues
Reconciliation Instructions in HConRes 85 Section 201
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareHealth Care Reform; Pathway to Covering America; Employer Based Healthcare System; Uninsured/Expanding Coverage; Effective Individual Mandate; Health Coverage Responsibility; Affordable Private Health Care; Government Plan Option; FEHBP; Healthcare Reform Model;
HR1321 and S391 "Healthy Americans Act"; HR1897 and S803 "Healthy Workforce Act of 2009"; American Health Choices Act
Insurance Market Reform; Individual Market Reform; Small Group Market REform; Small Business Healthcare; Guaranteed Issue; Community Rating; Health Status Rating; Health Savings Accounts/Medical Savings Accounts
Patient-centered Primary Care/Medical Home; Health Care Quality; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research; Improved Delivery of Health Care; Healthcare Delivery System Reforms
Antitrust and Health Insurance Reform
Federal Connectors; Virtual Connectors; State Insurance Marts (SIMs)
S.Res. 156 "A resolution expressing the sense of the Senate that reform of our Nation's health care system should include the establishment of a federally-backed insurance pool"
Health Information Technology Standards; Health Information Privacy; Electronic Health Records
S386 "Fraud Enforcement and Recovery Act of 2009" sections pertaining to the False Claims Act
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Biogenerics/Generic Biologics: HR1427 "Promoting Innovation and Access to Life-Saving Medicine Act"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
IRC Section 833(b) tax provisions
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2009
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 17, 2009.
Original Filing: 300153173.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: BUD-Budget/AppropriationsMedicare Advantage Funding: 2010 Medicare Advantage Rates
HR1 "American Recovery and Reinvestment Act of 2009" Section 3001 on COBRA Subsidies; Section 5001 on Medicaid funding; Sections 4101 and 4102 on Electronic Health Records; Sections on Health Information Privacy; Section 804 on Comparative Effectiveness Research; sections 1801 and 1899L on the Trade Adjustment Act
CHIP/SCHIP: HR2 and S275 "Children's Health Insurance Program Reauthorization Act of 2009"
Reconciliation Instructions in HConRes85 Section 201
Health Care Reserve Funds in HConRes85 Section 301 and SConRes13 Section 201
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareHealth Care Reform; Employer Based Healthcare System; Uninsured/Expanding Coverage; Individual Mandate; Affordable Health Care; Government Plan Option
Insurance Market Reform; Small Group Market Reform; Small Business Healthcare
Federal Connectors; Virtual Connectors; State Insurance Marts (SIMs)
Health Care Quality; Health Disparities; Wellness; Chronic Care Management; Comparative Effectiveness Research
Health Information Technology Standards; Health Information Privacy; Electronic Health Records HIPAA Privacy: HR1 "American Recovery and Reinvestment Act of 2009" Sections pertaining to HIPAA Privacy in the HITECH Act
Health Savings Accounts/Medical Savings Accounts (Tax)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Advantage
Medicaid
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Biogenerics/Generic Biologics: HR1427 "Promoting Innovation and Access to Life-Saving Medicine Act"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR1 "American Recovery and Reinvestment Act of 2009" - parts pertaining to the Trade Adjustment Act Health Care Tax Credit Section 1899A; Small Business Coverage Tax Credits
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2008
In Q4, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Jan. 19, 2009.
Original Filing: 300127137.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareHealth Information Technology Standards; HIT Privacy; Electronic Health Records; ICD10 Implementation: HR1368 "Personalized Health Information Act of 2007"; S1783 and S1693 "Wired for Health Care Quality Act"; HR3800 "Promoting Health Information Technology Act"; HR2406 "Healthcare Information Technology Enterprise Integration Act"; HR6357 "Pro(Tech)t Act of 2008"
Healthcare Reform; Insurance Market Reform; Employer Based Healthcare System; Small Group Market/Small Business Healthcare; Uninsured; Health Disparities; Connectors/Virtual Connectors; S1019 "Health Care Choice Act of 2007"; S334 and HR3163 "Healthy Americans Act"; S2795 "Small Business Health Options Program Act of 2008"
Mental Health Parity: S3712 "A Bill to make a technical correction in the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008"
TAA; HR3801 and S1848 "TAA Health Coverage Improvement Act of 2007"
Health Savings Accounts/Medical Savings Accounts
SCHIP; HR976 and HR3963 "SCHIP Extension Bill"
HR2851 and S400 "Michelle's Law"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Medicare Secondary Payor; Mandatory Insurer Reporting
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR2184 "Enhanced Health Care Value for All Act"; S3408 "Comparative Effectiveness Research Act of 2008"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR3920 "Trade and Globalization Act of 2007" and S1848 "TAA Health Coverage Improvement Act of 2007" - parts pertaining to the Health Coverage Tax Credit
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2008
In Q3, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on Oct. 20, 2008.
Original Filing: 300101732.xml
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareAntitrust and Health Insurance Reform: HR971 and S2161 "Community Pharmacy Fairness Act of 2007", S618 "Insurance Industry Competition Act of 2007"
Health Information Technology Standards; HIT Privacy; Electronic Health Records; ICD10 Implementation: HR1368 "Personalized Health Information Act of 2007"; S1783 and S1693 "Wired for Health Care Quality Act"; HR3800 "Promoting Health Information Technology Act"; HR2406 "Healthcare Information Technology Enterprise Integration Act"; HR6357 "Pro(Tech)t Act of 2008"
Healthcare Reform; Insurance Market Reform; Employer Based Healthcare System; Small Group Market/Small Business Healthcare; Uninsured: S1019 "Health Care Choice Act of 2007"; S334 and HR3163 "Healthy Americans Act"; S2795 "Small Business Health Options Program Act of 2008"
Genetic Non-discrimination: HR493 and S358 "Genetic Information Nondiscrimination Act of 2007
Mental Health Parity: HR1424 "Paul Wellstone Mental Health and Addiction Equity Act of 2007" and S558 "Mental Health Parity Act of 2007"; HR1424 as passed: sections pertaining to the "Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008"
TAA; HR3801 and S1848 "TAA Health Coverage Improvement Act of 2007"
Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"
HR2851 and S400 "Michelle's Law"
S2041 "False Claim Act Correction of 2007" as it pertains to the payment of healthcare claims
HR758 "Breast Cancer Patient Protection Act of 2007"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Medicare Part D; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"; Medicare Electronic Health Records; Pay for Performance; Medicare Advantage: HR6331 "Medicare Improvements for Patients and Providers Act of 2008", S3101 "Medicare Improvements for Patients and Providers Act of 2008", and S3118 "Preserving Access to Medicare Act of 2008"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR3920 "Trade and Globalization Act of 2007" and S1848 "TAA Health Coverage Improvement Act of 2007" - parts pertaining to the Health Coverage Tax Credit
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2008
In Q2, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on July 16, 2008.
Original Filing: 300067966.xml
Lobbying Issues
Medicare Advantage Funding: HR 6331 "Medicare Improvements for Patients and Providers Act of 2008"; S3101 "Medicare Improvements for Patients and Providers Act of 2008"; S3118 "Preserving Access to Medicare Act of 2008"; and Comparative Effectiveness Funding: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
See attached addendum for General Lobbying Issue Area: HCR - HealthcareAntitrust and Health Insurance Reform: HR971 and S2161 "Community Pharmacy Fairness Act of 2007", S618 "Insurance Industry Competition Act of 2007"
Health Information Technology Standards; Electronic Health Records; ICD10 Implementation: HR1368 "Personalized Health Information Act of 2007"; S1783 and S1693 "Wired for Health Care Quality Act"; HR3800 "Promoting Health Information Technology Act"; HR2406 "Healthcare Information Technology Enterprise Integration Act", HR6357 "Pro(Tech)t Act of 2008"
Healthcare Reform; Insurance Market Reform; Employer Based Healthcare System; Small Group Market/Small Business Healthcare; Uninsured: S1019 "Health Care Choice Act of 2007"; S334 and HR3163 "Healthy Americans Act"; S2795 "Small Business Health Options Program Act of 2008"
Genetic Non-discrimination: HR493 and S358 "Genetic Information Nondiscrimination Act of 2007
Mental Health Parity: HR1424 "Paul Wellstone Mental Health and Addiction Equity Act of 2007" and S558 "Mental Health Parity Act of 2007"
TAA; HR3801 and S1848 "TAA Health Coverage Improvement Act of 2007"
Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"
Health Savings Accounts/Medical Savings Accounts; SCHIP
S2041 "False Claim Act Correction of 2007" as it pertains to the payment of healthcare claims
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare; Medicare Part D; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"; Medicare Electronic Health Records; Pay for Performance; Medicare Advantage: HR 6331 "Medicare Improvements for Patients and Providers Act of 2008"; S3101 "Medicare Improvements for Patients and Providers Act of 2008"; S3118 "Preserving Access to Medicare Act of 2008"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
E-prescribing; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
HR3920 "Trade and Globalization Act of 2007" and S1848 "TAA Health Coverage Improvement Act of 2007" - parts pertaining to the Health Coverage Tax Credit
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2008
In Q1, Blue Cross and Blue Shield of Kansas, Inc. had in-house lobbyists. The report was filed on April 18, 2008.
Original Filing: 300044393.xml
Lobbying Issues
Antitrust and Health Insurance Reform: HR971 and S2161 "Community Pharmacy Fairness Act of 2007", S618 "Insurance Industry Competition Act of 2007"
Health Information Technology Standards; Electronic Health Records; ICD10 Implementation: HR1368 "Personalized Health Information Act of 2007"; S1783 and S1693 "Wired for Health Care Quality Act"; HR3800 "Promoting Health Information Technology Act"; HR2406 "Healthcare Information Technology Enterprise Integration Act"
Healthcare Reform; Insurance Market Reform; Employer Based Healthcare System; Uninsured: S1019 "Health Care Choice Act of 2007"; S334 and HR3163 "Healthy Americans Act"
Genetic Non-discrimination: HR493 and S358 "Genetic Information Nondiscrimination Act of 2007
Mental Health Parity: HR1424 "Paul Wellstone Mental Health and Addiction Equity Act of 2007" and S558 "Mental Health Parity Act of 2007"
Comparative Effectiveness Research: HR3162 "Children's Health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"
Health Savings Accounts/Medical Savings Accounts; SCHIP, Small Group Market/Small Business Healthcare
S2041 "False Claims Act Correction of 2007" as it pertains to the payment of healthcare claims
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare Part D; Comparative Effectiveness Research: HR3162 "Children's health and Medicare Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act";; Medicare Electronic Health Records; Pay for Performance
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...